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Research has shown that patients in the first two stages 
of HIV disease experience significantly higher levels of 
depression, mood disturbances and anxiety than do those 
patients with AIDS (Wadland & Gleeson, 1991). As a result of 
the Concorde Study, treatment for patients in these stages 
has changed to a more negotiable process often bringing 
health monitoring rather than active treatment. Survival in 
this stage of the HIV continuum will depend more on coping 
skills than on medical interventions. 
This experimental study (N=l9) examined the effectiveness 
of a six week biopsychosocial program "Living with HIV" as an 
intervention to decrease emotional distress, and increase 
personal control and medical compliance. Scales to assess 
emotional distress included: Beck Depression Inventory, 
Hamilton Depression Scale, Hamilton Anxiety Scale, Impact of 
Event Scale and Multidimensional Health Locus of Control, 
Form C. A Medical Review Log assessed appointment compliance 
for three months following the program. 
The quantitative findings combined with the participants 
subjective responses and actions to the study provided 
findings of clinical significance. The stress inoculation 
model of "preparation" was bidirectional in its application 
between those living with HIV, and those providing their 
medical and mental health care. 
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DEDICATION 
This research effort is dedicated to the individuals who are 
courageously living with AIDS, and to those who have died 
from AIDS. 
CHAPTER I 
DEFINING THE TOPIC OF THE STUDY 
"The challenge of HIV infections to society in 
general and health care professionals in 
particular represents the most dramatic and 
threatening public health problem of the decade, 
if not the century" (Cohen, 1990, p. 98). 
INTRODUCTION 
Having the Human Immunodeficiency Virus (HIV) is a 
major, stressful life event. It forces people to deal with 
many painful and difficult issues such as declining health 
with its attendant multiple losses, discrimination, and 
prejudice. The emotional distress that comes with living 
with HIV and its medical uncertainty is compounded by that 
of disclosing the diagnosis and one's risk factor to family 
members and employers. This action threatens or destroys 
one's supportive relationships from a personal, family, 
social, and employment perspective. The patient's battle 
for survival is dependent on the scientific and medical 
management of the virus and sustaining hope while combating 
the stresses of living daily with HIV. We are now into the 
second decade of extensive scientific research and clinical 
trials, but are still without a cure for the deadly virus 
that causes Acquired Immune Deficiency Syndrome (AIDS) . 
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Progress has been seen in the medical management of HIV 
through the timely use of prophylactic treatments to delay 
the onset of infections that further destroy the immune 
system. This focus on early intervention is a means to 
prolong life and delay the onset of AIDS through the 
appropriate use of antiretroviral drugs. Zidovudine (AZT) 
remains the most commonly used antiretroviral agent for 
treatment and is considered the first line of defense 
against this disease (Lipsky, 1994). The efficacy on the 
timely use of this drug has now been challenged. 
In light of the recent published data from the Concorde 
Study, the antiretroviral drug AZT has been shown to have 
limited effectiveness in terms of disease progression and 
survival in early HIV disease (Aboulker & Swart, 1993). In 
response, a panel of experts was convened by the National 
Institute of Allergy and Infectious Disease which 
recommended that medical intervention in the earlier stages 
must now focus on education and counseling. Decisions as to 
when to start medical therapy must become negotiable, 
creating a shift away from a paternalistic approach in 
medicine towards a doctor and patient partnership in medical 
decision making. These changes will add more uncertainty 
and an increasing level of stress for those living with HIV 
and those providing care. 
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STATEMENT OF THE RESEARCH PROBLEM 
With the major disruptions in the medical management of 
early HIV and the changes in treatment approach the 
possibility now exists that HIV-infected people in the early 
stage of the illness could experience a latency period in 
medical treatment, receiving health monitoring and 
counseling instead of active therapy. Survival in this 
stage of the HIV continuum will depend more on coping skills 
than on medical intervention. Research has shown that 
patients in the first two stages of HIV disease experience 
significantly higher levels of depression, mood disturbance 
and anxiety than do those patients with AIDS (Wadland & 
Gleeson, 1991). These disturbances, and a sense of 
helplessness and hopelessness, may be exacerbated by their 
need to rely on medical technology and a paternalistic 
approach to medical care. 
PURPOSE OF THE STUDY 
The purpose of this study was to examine the 
effectiveness of a biopsychosocial educational program in 
the pre-AIDS stage of the illness. This research project 
studied the efficacy of this model as a prophylactic 
intervention for decreasing stress that leads to depression 
and anxiety, while increasing the individual's health locus 
of control and medical compliance. This study was designed 
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from a cognitive-behavioral perspective utilizing the stress 
inoculation model to enhance coping, adaptability, and 
survival by creating hope, while at the same time helping 
people prepare for an illness defined by its uncertainty and 
unpredictability. This is a program of "preparation" that 
is contextual to the needs of HIV-infected patients and 
their loved ones as they proceed in their personal evolution 
and journey along the disease continuum to its final stage. 
RATIONALE 
In the current climate of health care reform and cost 
reductions, another layer of stress due to limitations of 
medical therapy is now being felt by people living with the 
HIV virus. This creates a significant need in this patient 
population for increased consumer education and mental 
health counseling that will promote a sense of control and 
empowerment in the earlier stages of this disease. The need 
exists for relevant and timely therapeutic methods for 
adaptive coping that seek to create synergy with the 
changing medical management for HIV in the early stages. A 
biopsychosocial perspective for mental health intervention 
serves as a "stress inoculation'' against the emotional 
despair of being HIV infected. Since the stigma and fear of 
AIDS continues to be felt in society by those infected and 
those that care about them an increasing need exists for 
medical, social, economic, and legal resources. 
DEFINITION OF TERMS 
For the purpose of this study, the following key terms 
were defined. 
HIV-INFECTED PERSON: An adult who has tested positive 
on the Enzyme-linked Immunosorbent Assay (Elisa) antibody 
and confirmed by the Western Blot test for HIV virus that 
causes AIDS. 
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DEPRESSION: Mood disturbance described as sadness, 
despair and discouragement. Symptoms may include feelings of 
helplessness and hopelessness with complaints of sleep 
disturbance, loss of appetite, fears of abandonment and 
death, along with a high risk for suicide. A range in levels 
of depression is universally experienced by HIV-infected 
individuals from a reactive to a clinical to an organic 
depression in the life-time of the disease. 
ANXIETY: Apprehension, tension, and fears universally 
experienced by HIV-infected people when the stress and 
threat of a catastrophic illness overwhelms their capacity 
to cope. The presentation of physical and verbal 
expressions of anxiety begins with their diagnosis and 
continues at various levels throughout the illness around 
issues of disclosure of diagnosis, changes in symptoms and 
in their CD4 (T-lymphocyte cells) counts threatening the 
ability to cope. 
MEDICAL COMPLIANCE: The extent to which a patient is 
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compliant to recommended medical advice by keeping scheduled 
clinic appointments. Information regarding compliance with 
clinic appointments was charted in the progress notes in the 
patients' medical chart. 
BIOPSYCHOSOCIAL EDUCATIONAL PROGRAM: A six week 
educational program designed from a medical model developed 
in a general systems conceptual framework to meet the 
patients' multidimensional needs from a biological, 
psychological, and social perspective. Each of these needs 
is given equal weight in clinical formulations from an 
interdisciplinary perspective in developing the program. 
STRESS INOCULATION MODEL: A cognitive-behavioral 
educational-skills-training approach of enabling behaviors 
as a "preparation" to empower people to cope with impending 
threatening events rather than being disorganized by anxiety 
or inappropriate actions as a result of denial of real 
dangers. 
HEALTH LOCUS OF CONTROL: The extent to which 
individuals believe their behaviors result in the ability to 
exercise some control over their health situation. And they 
recognize their internal influence on their health as well 
as the influence of powerful others on health care decisions 
and outcomes. 
RESEARCH HYPOTHESES 
This study examined four research hypotheses. The 
method for addressing their statistical significance is 
stated in Chapter III. The research findings are found in 
Chapter IV. 
Hypothesis 1: Participation in a biopsychosocial 
educational program will result in a decrease in 
anxiety in the experimental group compared to the 
control group. 
Hypothesis 2: Participation in a biopsychosocial 
educational program will result in a decrease in 
the mood disturbance of depression in the 
experimental group compared to the control group. 
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Hypothesis 3: The experimental group will show 
increased levels of locus of internal control 
versus physicians' and significant others' control 
as a result of their participation in the 
biopsychosocial educational program in comparison 
to the control group. 
Hypothesis 4: Participation in a biopsychosocial 
educational program will result in a higher level 
of medical compliance among the experimental group 
versus the control group for a period of three 
months following the completion of the program. 
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SIGNIFICANCE FOR CLINICAL SOCIAL WORK 
The dynamic interplay among the multidimensional needs 
of the HIV-infected person challenges Social Workers 
schooled in the biopsychosocial approach to promote survival 
through education and change. A vital need exists for 
Social Work leadership to develop multidisciplinary 
approaches for balancing the medical and psychosocial 
context of the disease with the internal and external 
strengths, resources, and supports that enhance coping and 
survival for HIV infected people. This holistic approach 
would create a triad of interactions between the person, the 
illness, and the environment. 
Working with this at risk population epitomizes the 
view of the social work profession as a contemporary 
practice that is contextual, interactive and multimethod in 
orientation and characterized by the person-in-situation/ 
person-in-environment interface (Saari, 1986). This 
psychoeducational program will help HIV-infected people to 
develop coping strategies that promote self-worth, 
self-esteem and options to "live with" rather than "die 
from" HIV/AIDS. This research effort speaks to the inherent 
social work values. And these values in purpose and method 
have an ethical responsibility to honor, to preserve, and to 
facilitate the patient's self-determination (Levy, 1983). 
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ASSUMPTIONS OF THE STUDY 
This study was predicated on the assumption that the 
organizing content of the biopsychosocial educational 
program "Living with HIV" is a useful modality for HIV 
infected adults in the pre-AIDS stage of disease that merits 
attention. It was assumed, based on the literature and 
clinical observations, that the stressful situations 
impinging on this population lead to anxiety and depression. 
It was further assumed that cognitive-behavioral methods for 
addressing these stressful situations could result in 
strategies to increase coping abilities and decrease 
emotional distress. 
The medical setting represents the major resource for 
the HIV-infected population. This study then assumed that 
the study methods and site would prove highly relevant for 
their needs. Further it assumed that graded exposure to the 
medical and psychosocial aspects of this disease is most 
appropriate for this setting, and that the interactions with 
their medical care team will provide a model for the present 
and future needs. 
Finally, it was assumed that a program based on the 
stress inoculation model of preparation in the earlier 




AIDS, and its manifestations of the HIV infection is a 
paradigm of a medical illness in crisis. Changes in the 
early medical management of the HIV disease creates a 
challenge for an equal focus on the psychosocial management 
of the disease for those who are HIV-affected. One approach 
is a biopsychosocial educational program utilizing the 
stress inoculation model to create synergy between the 
changing medical care and the psychological, social, and 
environmental affront to patients' existence. This 
structured program is designed to provide opportunities to 
create equilibrium between the crisis reaction to being 
HIV-infected and the capacity for enhancing coping 
strategies to live daily with this disease. 
CHAPTER II 
REVIEW OF THE LITERATURE 
In response to a paradigm in crisis, Kuhn (1970) 
states "let us then assume that crises are a 
necessary precondition for the emergence of novel 
theories and ask next how scientists respond to 
their existence" (p. 77) . 
INTRODUCTION 
The Human Immunodeficiency Virus (HIV) , with its 
manifestations that lead to Acquired Immune Deficiency 
Syndrome (AIDS) , is a paradigm of a medical illness in 
crisis. Now after more than a decade of extensive research 
and clinical trials in a consistent effort to unravel the 
secrets of the HIV virus, the scientific world is still far 
from developing therapy to abate its advancement, let alone 
find a cure. In fact, a recent study revealed that the one 
drug that the medical community put all its hopes on, AZT, 
proved less effective over time in prolonging life and 
delaying the onset of AIDS than first anticipated. This 
unwelcome reality in the medical care of HIV-infected people 
creates a shift in the decision making process away from the 
dependency on medical technology and towards the creation of 
a partnership in care. It is now possible that infected 
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people in the earlier stage of the disease will depend more 
on coping skills than on medical intervention. 
In the 1980's when AIDS was first diagnosed, the fever 
pitch for scientific intervention left hope for both control 
and cure of this deadly disease. Behavioral research at 
that time focused intensively on risk reduction change 
processes and, to a lesser extent, on the mental health 
needs of persons infected with HIV disease (Kelly & Murphy, 
1992). The need now exists for research models of 
intervention that facilitate the psychological well-being of 
HIV-infected people, a cognitive-behavioral focus that will 
empower, sustain, and engage them in their health care in 
the earlier stage of the disease. 
The following literature review was organized to be 
used in two ways: as a resource to support the clinical 
significance of the study, and as a tool in the therapeutic 
framework for intervention. The literature review includes: 
a) stages of HIV disease; b) impact of the earlier stages of 
disease; and c) theoretical framework for intervention. 
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STAGES OF THE HIV-DISEASE 
AIDS is a life-threatening illness caused by the HIV 
virus that severely attacks and weakens a portion of the 
immune system. When the damage is severe, the body is left 
unable to fight off certain infections and cancers that 
healthy immune systems destroy with ease. The virus spreads 
by specific behaviors that directly expose one person's 
bloodstream to the infected body fluids of another, such as 
blood, semen, or vaginal fluid. The Center for Disease 
Control (CDC) reports that 17 million people in the world 
are infected with the HIV virus. The total number of 
infected persons in the United States is currently estimated 
at one million or about 1 in 250 persons. Those diagnosed 
with AIDS by the end of 1994 will be between 415,000-
535,000, and the number of deaths to date along with 
projected deaths by the end of 1994 will be 312,000-385,000 
(CDC, 1994). Statistics continue to draw our awareness to 
the devastation of this disease and the concomitant 
limitations of medical interventions. The HIV/AIDS virus is 
now the leading cause of death among American adult males 
ages 25-44 (CDC, 1995). 
Exposure to HIV is greatest among a population engaging 
in high risk sexual and/or drug abuse behaviors. The 
majority of people infected with the virus in the United 
States are homosexual and bisexual men at 49%. A decline 
continues in this population due in large part to a well 
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orchestrated educational effort in the gay community. The 
areas of increase are among intravenous drug users (IVDU) at 
33%, and women, due to both intravenous drug use and 
heterosexual contacts at 17% (CDC, 1995). Today, the most 
rapidly growing populations infected with HIV are women and 
teens. And with the growing number of women infected with 
HIV, health care providers are witnessing a rising number of 
newborn children also infected. AIDS is now the leading 
cause of death for young women between 21-35 years old in 
four major cities in the United States (CDC, 1994) . 
The first medical model of AIDS was that of a disease 
with an acute onset and a prognosis of two years or less. 
Prolonging life is now possible due to scientific advances 
in the identification of biological markers and antiviral 
therapies that slow down or control some infections. This 
has resulted in a reconceptualization of the HIV virus as a 
chronic illness (Grohman & MacDonell, 1992). The clinical 
view of the HIV virus is that of stages on a continuum from 
seropositive asymptomatic status to AIDS, the final stage. 
Although disease progression varies widely among individuals 
(Hamburg & Fauci, 1989) the three stages of illness 
typically will unfold between nine to twelve years from 
infection to AIDS: 
Stage 1) . an asymptomatic period of more than four 
years average duration. 
Stage 2) . symptomatic with AIDS-related complex for 
about five years. 
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Stage 3). AIDS characterized by various opportunistic 
infections, i.e., HIV wasting, HIV dementia, lymphomas, 
and CMV retinitis on an average of nine to 12 months 
for treated and untreated individuals combined, and 21 
months for those receiving antiretroviral treatment 
(Lemp, et al., 1990). 
It now appears that the diagnosis of AIDS will develop in 
most, if not all, HIV-infected individuals (Grohman & 
MacDonell, 1992). 
The utility of a staging system explicitly imposes both 
a structure on the natural history of the disease and 
provides clinical markers for intervention (Royce, et al., 
1991) . Souri (1991) uses the stages as a schematic that 
provides his patients with both a basic knowledge of the 
disease and progression while also providing a realistic 
assessment of life expectancy. He does not indicate 
however, what other counseling sources he utilizes prior to 
and after this frank discussion. 
Along with stages comes the biological markers of CD4 
{T-lymphocyte cells) counts, the direct measure of the 
immunologic status that dictates treatment decisions (CDC, 
1992) . For this reason, CD4 counts are closely monitored 
16 
not only by the physician but the patient as well. The rise 
and fall of these counts due to multiple variables often 
results in general emotional distress, mood disturbance and 
anxiety for patients and their loved ones. The normal range 
for CD4 counts is 1000 with a plus or minus of 500 
lymphocyte cells. An expanded classification system of 
stages includes corresponding CD4 counts and illustrates 
when medical interventions are indicated: 
Stage 1./Category 1: ~(greater than) 500 T-cells 
Stage 2./Category 2: (between) 201-499 T-cells 
Stage 3./Category 3: ~(less than) 200 T-cells (MMWR, 
1992) . 
Inherent with this classification system is the 
knowledge that infected people enter medical settings at 
various points on this continuum. This demands a 
bio-psychosocial assessment of the patient with 
interventions that are stage appropriate from the medical, 
psychological and psychosocial perspectives. 
The paradigm of the AIDS illness that dictated medical 
management of early HIV infection has changed since the 
publication of the Concorde Study at the Ninth and Tenth 
International Conference on AIDS in 1993 and 1994, 
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respectively. This three year randomized, double-blind, 
placebo-controlled study found no significant benefits, in 
terms of either survival or disease progression, of early as 
opposed to delayed use of AZT, irrespective of the CD4 count 
(Aboulker & Swart, 1993; Lipsky, 1994). Before the report, 
newly infected people were typically started on AZT when 
their CD4 count was 500 or greater. 
In response to the study, a panel of experts convened 
by the National Institute of Allergy and Infectious Disease 
offered several modifications of this and other aspects of 
treatment. First, they argued that in the absence of any 
clear advantage to early initiation of AZT, the decision of 
when to initiate AZT should become more of a negotiated 
process between the physician and the patient (Glick, 1993) 
Second, they strongly encouraged more education and 
counseling in the earlier stages of the illness. Third, 
they stressed the importance of creating a partnership in 
treatment decisions not only in early but also in advanced 
stage of the illness (Glick, 1993). Summarizing the new 
directions, Glick (1993) felt "the choice to accept or 
decline antiretroviral therapy will rest ultimately with the 
patient (p. 6). 
In many clinical settings these recommendations 
represent a major departure in medical practice for both the 
physician and the patient. To execute them would entail a 
cognitive reframing in decision making from the patients' 
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dependency on technology to a collaborative process that 
involves more control, that is more empowering for the 
patients. It is possible that HIV-infected people in the 
earlier stages of the illness will experience a latency 
period in medical intervention, instead of active medical 
therapy they will undergo health monitoring and counseling. 
In fact, in the overall sequence of stages through which 
they will live and cope with this fatal disease, patients 
will spend the greatest amount of time in these early 
stages. 
IMPACT OF HIV DISEASE IN THE EARLIER STAGES 
Testing positive for HIV is a major stressful life 
event with feelings ranging from a period of shock and 
numbness, to excessive intrusive thoughts (Cohen, 1990; 
Ferrando, 1992; Wadland & Gleeson, 1991). Hearing that one 
has a disease without a cure, with limited available 
therapies, high elements of uncertainty, and a 
stigmatization from a society intolerant due to the route of 
transmission, is a crisis. Living with the stress of this 
chronic illness is compounded by living with the daily 
stresses of the 90's and the pervasive feelings of 
insecurity. The reality of being HIV infected brings fears 
of infecting others, telling others, and losing the love and 
support of others. The crisis in this early stage, as 
Wadland and Gleeson (1991) have observed, is expressed in 
symptoms of depression such as helplessness, hopelessness 
and worthlessness. 
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Being out of control is one of the most common basic 
fears. The crisis in learning that one has the HIV virus 
ignites this basic fear and often results in behaviors in 
search of control. Upon receiving the positive test results 
many people will challenge the validity of the test and the 
laboratory's credibility with demands to be retested. The 
resulting reenactment of the waiting period produces 
incredible stress and anxiety only to hear the confirmation 
that changes their lives forever. 
The cognitive theory of stress and coping (Lazarus & 
Folkman, 1984) is centered on the ability to appraise 
personal control in a given event for stress reduction and 
adaptive coping. The reality testing of one's appraisal 
creates a balance between problem-focused and emotional-
focused coping. However, situations of uncertainty and 
ambiguity prevent the necessary cues from which to make 
these determinations. An ensuing imbalance of emotional-
focused coping occurs and a defense such as denial 
dominates. 
Upon learning of his positive test during a routine 
physical exam a 27 year old man who claims a monogamous 
relationship for seven years, refused to accept the 
results. This was further reinforced when his partner 
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tested negative. He proceeded to be retested in four 
different medical settings. To his despair, they were 
all positive, and he was in the late stage of the 
disease. And his denial continued. As his counts 
declined and his disease progressed he still refused to 
take any antiretroviral therapy. 
Traditionally, denial has been viewed as a maladaptive 
defense that interferes with our perception of reality, a 
hallmark of mental health. Denial, however, is an important 
coping defense for many HIV-infected people, for it allows 
them to continue to live "as if 11 the disease was not fatal, 
a workable strategy today given the limits of the scientific 
achievements against the HIV virus. Lazarus (1985) in his 
review of the cost and benefits of denial speaks of a 
"partial" denial that involves the capacity to bring the 
denied reality into awareness when necessary. An example of 
this is the reality of being at risk for HIV and being 
tested. The cost side of this denial is evident in the 
failure to return for results and avoidance of symptoms 
only to be suddenly admitted to a hospital with a 
progressive life-threatening illness. A crisis ensues for 
the patient and loved ones who were unaware and unprepared. 
In our western society, personality is often predicated 
upon a powerful denial of finitude. Denial allows us to 
plan for the future, raise children and develop careers and 
contribute to society. Being HIV infected pierces that 
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important denial and leaves many individuals vulnerable to 
extreme existential anxiety. But it is also the process of 
denial that provides the individual the proper pacing in the 
revision and rebuilding of one's basic theories and 
assumptions of life (Janoff-Bulman & Timko, 1987) . This 
important defense, when balanced in the context of the 
stress and coping theory, provides temporal transitions and 
the cognitive reframing from fear to hope. 
The ability to prolong life through timely 
interventions has changed HIV from an acute to a chronic 
illness. Among the factors that enable patients to cope 
with a chronic illness is their belief in the ability to 
control their own health. A study examining feelings of 
control and adjustment to physical illness was conducted 
among patient's with cardiac disease, cancer and AIDS. The 
results found that belief in personal control is generally 
adaptive and appears to reduce anxiety. However, patients 
that tended to profit psychologically from a sense of 
personal control were patients with a good prognosis, as 
opposed to those with a poor prognosis (Taylor, Helgeson, 
Reed, & Skokan, 1991) . 
Folkman (1984) theorized that the generalized beliefs 
about personal control that individuals assume over 
important outcomes is a major influence in their cognitive 
appraisals of an event. Rotter (1975) formulated these 
beliefs into the internal-external locus of control studies. 
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Here events are contingent on the actions of one's own 
behavior as internal control, and the actions of powerful 
others as external control. Wallston and colleagues (1978) 
developed the Multidimensional Health Locus of Control Scale 
based on Rotter's formulation with an interest in beliefs of 
personal control over one's health situation. These scales 
have been recently expanded (Wallston et al., in press) that 
further splits powerful others between physicians and 
significant others. This dichotomy is a repeating theme on 
the HIV continuum between the patient's desire for control 
and use of alternative methods compared to physician 
control. Differences often result in issues of compliance 
and noncompliance with the medical management of this 
illness. 
Research conducted on the three clinical stages of HIV 
disease shows that patients in the first two stages 
experience significantly higher levels of depression, mood 
disturbance and anxiety than do those patients with AIDS 
(Wadland & Gleeson, 1991) . This has important clinical 
implications since there are indications to suggest that 
people with AIDS would experience greater psychological 
disturbance given a shorter life-expectancy and increasing 
medical complications. Linn et al. (1993) in his study of 
depression and anxiety in adults infected with HIV 
hypothesized that people with more advanced HIV-related 
illness would experience higher levels of depression and 
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anxiety. This community based study (N=156) used self 
reporting scales that involved the Center for 
Epidemiological Studies Depression Scale, Anxiety Scale and 
the Perceived Coherence Scale with a predominately educated 
young male sample. 
Study results indicated that the stage of HIV illness 
does not influence the respondents' sense of meaning and 
purpose, or their depression or anxiety. However, measures 
used to determine the stage of illness were based on 
reported symptoms over a 30 day period of time, and not 
interfaced with the CD4 counts, the accepted staging 
criteria. The study also found that regardless of the stage 
of illness, the degree to which patients derived meaning and 
purpose was a significant predictor of their level of 
depression and anxiety. 
In another study, as part of a military universal 
screening for HIV, 422 men were diagnosed seropositive. They 
were further assessed for symptoms of anxiety and 
depression. Using both the Hamilton Anxiety Scale and 
Hamilton Depression Scale, 84.4% had the presence of 
anxiety and depression in the earliest stages of the 
illness (Brown, et al., 1992). 
The relationship between stressful situations and 
psychological distress is commonly observed in patients 
suffering from a chronic illness (Cella, Mahon & Donovan, 
1990; Folkman, 1993). The chronicity of HIV has a course 
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that will wax and wane over several years. The stressful 
impact of this illness is felt with the rise and fall of the 
individual's CD4 counts indicating disease activity. A 
study to measure the impact of disease recurrence was 
conducted on cancer patients who had been cancer free for at 
least six months and who experienced a recurrence. 
Instruments utilized in this study were the Impact of Event 
Scale and the Psychosocial Adjustment to Illness Scale given 
to forty eligible participants with a mean age of 60 years 
old. A significant stress response was evident on the 
Intrusion and Avoidance subscale of the IES. The mean 
Intrusion score was 18.0 (SD= 7.5) and the mean Avoidance 
score was 24.6 (SD=8.0). The researchers felt the results 
indicated these patients demonstrated as much stress-related 
symptomatology as people who present with trauma-induced 
stress disorders (Cella, Mahon & Donovan, 1990) . 
ANXIETY 
The severe psychological stress associated with HIV 
infection also contributes to a greater prevalence of 
adjustment reactions with depressed or anxious mood than in 
the general population (Levine, et al., 1991). The 
experience of anxiety is universal at some point in 
asymptomatic or symptomatic HIV or AIDS individuals. 
However, about 30-50% of this population go on to meet 
DSM-III-R criteria for anxiety related disorders (Ferrando, 
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1992) . Anxiety for HIV-infected people is expressed in 
themes of danger or harm to themselves or to significant 
others, from the severity of panic attacks to the subtleness 
of inquiry. Differentiating what are unrealistic or 
excessive worries about bodily functions is made more 
difficult with HIV as it often presents with vague and 
diffuse symptoms. 
A dynamic often seen with HIV-infected people is the 
cycle of vigilance "when I'm healthy I look for sickness" 
versus "when I'm sick I look for wellness." The anxiety of 
waiting for "something to happen" is expressed often among 
patients in the earlier stages. One patient was so 
overwhelmed with anxiety upon learning his diagnosis that he 
took to daily body scanning and examinations. He kept a 
flashlight in his bathroom to check inside his mouth and 
other areas of the body for any sign of change. He would 
also put on gloves upon entering his apartment and kept them 
on to protect him from any infections from his pet cat. 
The anxiety heard in those who are well is also heard 
in those who are sick, creating another waiting cycle. 
Another patient whose progression of disease had become more 
complicated defined his vigilance in the following way: 
"when I was sick before I had HIV there was always that 
moment when you knew you were getting better. You 
could feel yourself getting over the hump - now I look 
for that hump each day". 
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Another anxiety provoking experience for those newly 
diagnosed is the fear of losing control over one's thought 
processes. They often complain that they are "not on top of 
things", a way of indirectly asking if they are mentally in 
control. For the well-informed, the fear of developing AIDS 
Dementia often leads to HIV Anxiety with symptoms that 
produce impairment in concentration and memory (Perry, 
1990). 
Many of those who are themselves infected are also 
living with HIV-related stresses that include the illness of 
partners, spouses, or family members. A major concern in 
this population is the repeated exposure to the trauma of 
death as caregivers and powers-of-attorneys producing 
features of post-traumatic stress disorder. This is often 
expressed in dream recollections and confusion between 
symptoms of others and their own, along with intrusive 
thoughts in the form of flashbacks. Anxiety and the 
overwhelming fears about general well-being and the loss of 
control are also heard in the discontinuity of "feeling 
well" yet having a disease that is life-threatening. It 
creates a sense of urgency and panic over what to do first. 
"Who can I tell, not who should I tell," now occupies and 
worries the infected person's thought processes. 
Clinical experience with HIV infected people in the 
first stage finds that, due to emotional distress, many 
begin to prematurely plan and prepare for death due to their 
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feelings of helplessness and hopelessness. They tend to 
withdraw in their work focus or professional career goals. 
This can often lead to poor judgment and premature 
disclosure at work that threatens the loss of job, identity, 
income, benefits, and a quality of life. This phenomenon is 
often referred to as the Magic Johnson Syndrome. 
The degree of generalized anxiety in this population 
will vary according to personality, culture, coping styles 
and stage of illness. Its outgrowth is the result of 
adjustment reactions to being HIV infected. Those 
struggling for control tend to overwhelm themselves with 
massive educational materials and alternative treatments. 
They are determined to be that first person who will "beat'' 
this disease. Others with dependency issues experience 
overwhelming feelings of helplessness and endure greater 
adaptive problems in asserting their rights and 
entitlements. And still others will act out their fears 
with high risk and self-destructive behaviors such as unsafe 
sexual contacts, alcohol and drug abuse. 
DEPRESSION 
Depression is another universal reaction to a 
life-threatening illness that ranges from reactive to 
clinical and organic, of which an estimated 20-60% meet the 
DSM-III-R criteria for major depressions some time in their 
illness (Ferrando, 1992) . Inherent with this disease that 
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causes immunosuppression is the dual effect on the central 
nervous system. Perry (1990) has found in his clinical 
practice that HIV-infected adults experience a subjective 
sense of mental slowing, forgetfulness, apathy, lethargy, 
social withdrawal, avoidance of complex tasks and 
personality change before the development of AIDS. A major 
difficulty for clinicians is distinguishing depression from 
the physical and/or organic symptoms from the HIV disease. 
Beck (1985) saw three major negative patterns triggered 
by depression in the individual: a negative view of self; a 
negative view of experiences and the world; and the loss of 
an expected future. This triad of cognitive patterns is 
clinically expressed by HIV-infected individuals who 
describe feeling defective and separate from the rest of 
society. ·Individuals attach a prevailing sense of shame and 
worthlessness to their diagnosis that is overwhelming and 
dysfunctional. The negative experiences of rejection and 
abandonment are recurring themes as the disease unfolds, 
leaving a view of the future filled with unsurmountable 
obstacles. And finally, the remeasured life span of those 
infected with HIV creates an irreversible alteration in 
their future with the process of saying goodbye and 
preparing for death. 
For homosexual and bisexual men the comorbidity between 
emotional distress and HIV has been established (Cohen, 
1990; Ferrando, 1992; Levine et al., 1991; Perry et al., 
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1990). This factor further impacts on the psychological 
distress of being a member of a minority sexual culture. 
Perry (1990) found a 50% lifetime prevalence for depression 
in two major risk groups, homosexual and IVDU populations, 
prior to testing. It was felt that the emotional distress 
of being in this minority culture would result in higher 
scores on distress scales regardless of the HIV diagnosis 
(Britton, Zorski & Hobfall, 1993). Symptoms such as 
insomnia, low energy and motivation, decreased appetite, 
decreased libido, guilt, suicidal ideation and decreased 
concentration overlap with commonly seen symptoms in HIV. 
Depression tends to become chronic after the initial 
"adjustment reaction,'' especially in patients with a prior 
history of depression. 
For gay men diagnosed with HIV the fears of disclosure 
dominate the fears of the disease. A major clinical issue 
with this population is the timing of the diagnosis with the 
coming out process. How the patients cognitively structure 
the event is related to their underlying beliefs, attitudes 
and assumptions about themselves (Beck, 1985). Having HIV 
according to Cohen and Abramowitz (1990) "may stir up 
self-blame, self-hatred, and internalized homophobia in 
certain gay or bisexual men" (p. 163). Along with these 
feelings are the issues of guilt and shame. Stone (1992) 
re-examined the role of shame in the post-traumatic stress 
disorder. He saw the affects of shame and guilt as 
coassembled with fear, specifically the fear of punishment 
for a wrongful act. 
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Being HIV threatens the secretive lifestyle for many 
gay men unknown to family, employers and even neighbors, 
resulting in withdrawal. Anxiety and depression surround 
the dilemma of who to tell, when and how. Fierson (1987) 
found that communication was most strained between 
homosexual men with AIDS and their fathers, and least 
difficult between siblings. The art of maintaining secrets, 
not giving them up, has been a surviving technique in this 
culture. But as one gay infected man explained to his 
partner "being HIV is like being pregnant, it will soon have 
to come out". 
Survivors' guilt is another dynamic that leads to 
depressive symptoms in this population. The mere fact of 
surviving, of existing, when your partner has died creates 
distress. Given modern medical advances, death among young 
people has long since ceased to be normal - but not for gay 
men. Clinics and physician off ices continue to see many of 
the partners and friends of the earliest AIDS casualties 
whose role as caregivers brings "experience-near" 
familiarity with HIV. They often speak of these experiences 
as a mirror reflection of their own destiny. This 
population has had to endure massive losses with unresolved 
grief making death less an individual event, and more an 
environmental event (Sullivan, 1990). With the loss of so 
many friends, patients' resources for support and care are 
limited, if not exhausted. 
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Newly diagnosed people whose risk factor was (and, for 
many, continues to be) intravenous drug use (IVDU) bring a 
history of depression and maladaptive coping to their new 
medical crisis. Perry (1990) found this major risk group 
had a 50% lifetime prevalence for depression prior to 
testing for HIV. Cohen (1990) postulated that 
psychopathology has a major role in the initiation, onset 
and course of AIDS in this population. Khantzian (cited in 
Cohen, 1990) has proposed that IV drug users are depressed 
individuals who seek drugs to medicate their depression. 
The affective disorders associated with buying, selling, and 
using drugs, coupled with HIV, places these individuals at 
an increased risk for suicide. 
The chemically dependent person enters the medical 
setting with a well developed denial system and self-
destructive behaviors. Attempts at cognitive restructuring 
for risk reduction behaviors, medical compliance and 
adaptive coping are made extremely difficult. The addictive 
habits which served to conceal the anxiety and depression in 
their lives prior to HIV are revisited during the early 
stage resulting in relapse. Unfortunately, the HIV disease 
with its debilitating processes eventually forces compliance 
when they lose ability to physically, cognitively and 
economically care for themselves. 
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Women constitute the fastest growing subset of the AIDS 
pandemic in the United States. HIV disease is more 
complicated, less understood and more misdiagnosed for women 
than any other subgroup. Very little literature exists for 
this population as most research and clinical trials have 
focused on the homosexual/bisexual male. But this is 
beginning to change. A study in Milan, Italy investigated 
the psychosocial problems of 71 HIV positive and negative 
women. The sample was of predominately single women, 
average 26 years, who were actively using intravenous drugs. 
Scales for anxiety, depression, social support and locus of 
control were utilized. 
The findings revealed little difference between the 
groups. In fact, those who were HIV seropositive had lower 
levels of psychological morbidity. However, the findings 
did show that women with or at risk of HIV disease showed 
high levels of anxiety, depression and distress with a 
predominate external locus of control. It also found little 
use of condoms on a regular basis even for those infected. 
This important area of concern brought highly recommended 
psycho-educational interventions of counseling and support 
for those settings where women at risk or HIV-infected 
receive their medical care (Pergami et al., 1993). 
Women, especially middle-class, heterosexual women do 
not perceive themselves to be at risk for contracting the 
HIV disease (Stentzner-Gibson, 1991). As a result, the 
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response to their diagnosis tends to include a more intense 
denial with a decidedly heightened anger and rage. Feelings 
of betrayal from their partner can be overwhelming as can 
the profound grief over the losses of their health, body 
image, and childbearing potential. Women with children have 
the additional burden of guilt and fears for their 
children's health and their future. 
Suicidal ideation, with and without intent, among 
persons with AIDS is many times greater than that of the 
general public (Cohen, 1990; Wadland & Gleeson, 1991; 
Ferrando, 1992). Levine et al. (1991) states that among 
patients with catastrophic disease, HIV patients have 
reported the highest suicide risks. McKegney and O'Dowd 
(1992) studied suicidality in their Psychiatric Consultation 
Service in a medical hospital. Their data indicated a lower 
level of suicidality among patients with AIDS compared to 
early stage HIV patients. The organicity level with 
delirium and dementia in AIDS patients enhanced the use of 
denial, an association reported over decades. Another 
factor is that the fear of uncertainty in early HIV is 
eliminated with the diagnosis of AIDS, allowing the person 
to begin facing and mastering his fears of death. 
Features that contribute to the risk of suicide are 
feelings of hopelessness, impulsivity, substance abuse, 
illness, loss and grief, all now layered with the diagnosis 
of HIV. The premorbid history of depression and suicide 
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attempts increases that risk. But for others, suicide as a 
future option is an attempt to take control of one's own 
destiny. 
THEORETICAL FRAMEWORK FOR INTERVENTIONS 
Several models for coping with stressful life events 
were found in the literature (Hobfall & Wolfisch, 1986; 
Shontz, 1975; Silver & Wortman, 1980). The models appear to 
share similar patterns and stages with a consensus on 
several facts: 1) people respond to crisis in specific, 
predictable ways - shock, anger, depression; 2) individuals 
go through a series of stages over time in attempting to 
come to terms with their aversive life events; and 3) people 
experience affective mood distress and anxiety. 
In a theory of cognitive adaptation to threatening 
events, Taylor (1983) found in her research with breast 
cancer patients three dominant themes: 
1) a search for meaning of the event; 
2) attempts at regaining mastery and control over the 
event and over life in general; and 
3). an effort to restore one's self-esteem through 
self-enhancing activities. 
It is suggested that successfully resolving these 
concerns begins with the creation and maintenance of a set 
of illusions. These illusions are not intended to distort 
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reality, but cognitively reframe the facts in a particular 
light that promotes both the courage and the will to 
continue on in the face of adversity. A goal then of 
clinicians is to consistently appeal to the cognitive 
capabilities of the patient. Goldstein (1990) found that 
"effective practice is less a technical enterprise than it 
is a creative, reflective, and to a considerable extent, an 
artistic and dramatic event" (p. 38). Cognitively creating 
and maintaining hope for a cure, treatment, and time is a 
necessary goal (illusions) for HIV-infected people living 
with liminality (on the edge) . 
Perry et al. (1990) studied the effectiveness of three 
psychoeducational interventions on newly HIV tested 
individuals. The subjects were randomized to either 
standard counselling, six weeks of individual sessions of 
stress inoculation training, or three weeks of 45 minute 
video programs. Using self report and observer rated scales 
including the Beck Depression Scale, the study indicated 
that six week individual sessions with stress reducing 
techniques were most effective in reducing depression and 
anxiety. He concluded, however, that the difference in the 
response for each format may change in the different stages 
of the infection. 
Cognitive approaches at reducing anxiety and depression 
for newly diagnosed people were the focus of a study by 
Wolcott and Fowzy (cited in Levine, et al., 1991) who found 
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that a ten week psychoeducational support group proved more 
effective as an intervention than a psychotherapy drop-in 
group. Levine et al. (1991) found their twenty week session 
psychoeducational group had very positive outcomes measured 
by improvement on the Hamilton Depression and Hamilton 
Anxiety Scales. They also found the group experience most 
helpful in the promotion of and participation in medical 
research protocols. 
Namir et al. (1987) evaluated the relationship between 
different coping strategies and the psychological and health 
status of people with AIDS. They found that those who 
engaged in avoidance coping had a higher level of depressive 
symptoms, while those using active behavioral strategies had 
a lower mood disturbance. Most importantly, they found that 
strategies that focus on the maintenance of self-worth will 
increase feelings of control and combat passive, helpless 
feelings and despair (p. 326). 
The sum of all variables for coping with HIV disease 
lies in the challenge and capacity to live daily with the 
illness. Siegel and Krause (1991) was the only study that 
qualitatively examined this issue with HIV-infected people 
in the pre-AIDS stage. The themes that emerged from the 
data provided three broad adaptive categories: 
1). dealing with the possibility of a curtailed life 
span (creating a sense of urgency to obtain life goals, 
deciding to what extent to invest in the future) . 
2). dealing with reactions to a stigmatizing illness 
(deciding whom to tell about their diagnosis, and 
dealing with feelings of shame and contamination) . 
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3). developing strategies for maintaining physical and 
emotional health (control and vigilance about one's 
health) . 
In looking at factors that influence the adaptive 
process for chronic illness, Turk (1979) focused on personal 
meaning. He felt personal meaning is created in a triad of 
interplay between the individual person, the illness and 
environmental factors. The patient's appraisal of his or 
her situation and its ascribed meaning is translated into 
behavioral responses back to the environment. It is 
important to realize that this dynamic is constantly 
changing and is bidirectional, with each element acting on 
the other. 
The situational appraisal of control and coping are the 
two mediating processes in Lazarus and Folkman's (1984) 
theory on stress and coping. When a situation is appraised 
as controllable, the coping tends to be more planful with 
decreases in emotional distress. Conversely, the more 
uncertain and ambiguous the situation and less controllable, 
the more likely the use of emotional-focused coping, and 
increased distress. Folkman et al. (1993) examined the 
coping appraisals of 425 gay men who completed self-report 
questionnaires by mail. They found that those who assessed 
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their situation as controllable used active strategies in 
coping and showed decreased depressed mood, while those who 
appraised their stress as low on controllability used 
escape-avoidance coping and had increased depressed mood. 
The combined impact in the earlier stages of HIV of 
personal meanings of demoralization and fears and the 
growing uncertainty in treatment choices suggests the need 
for interventions that enhance perceptions for situational 
appraisals and strategies for survival with the current 
societal stresses. 
STRESS INOCULATION MODEL 
The stress inoculation model is a therapeutic 
intervention aligned with cognitive behavioral modification 
(CBM) or cognitive behavioral therapy (CBT) . This widely 
adopted form of psychotherapy has been evolving since the 
1970's. CBT combines the basic principles of cognitive 
therapy with behavioral activities to invoke adaptation and 
change in a short-term therapy format (Meichenbaum, 1992). 
Basic principles of CBT recognize that behavior is 
reciprocally determined; that emotions drive personal 
schemas; that behavior is phenomenologically oriented; and 
that collaboration and discovery processes are critically 
important. Other psychotherapeutic techniques subsumed 
under CBT are cognitive restructuring, problem-solving, 
anxiety management training and self-instructional training 
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(p. 115) . 
CBT has proven to be an effective intervention for 
generalized anxiety, depression, phobias, panic disorders, 
psychosomatic illness and pain control (Beck, 1993; 
Chambless & Gillis, 1993). The literature indicates a 
growing interest in this approach for therapeutic 
intervention for depression with people with HIV (Fishman, 
1990, cited in Beck, 1993; Kelly et al., 1993). This is 
also true for the application of stress inoculation training 
for HIV populations (Perry, 1991). However, the literature 
supports a wider application of the stress inoculation 
training for anxiety, anger, posttraumatic stress disorders 
for rape victims, and surgical preparations in the general 
population. 
Meichenbaum (1983) found there is an affinity between 
the transactional model of stress and the stress inoculation 
approach. The intervention procedures assist individuals in 
gaining the skills needed to manage and reduce stress, alter 
cognitions and develop adaptive behavioral coping strategies 
to reduce emotional distress (Kelly et al., 1993). Berlin 
(1983) found that the CBT analysis of coping suggests "that 
the transactions between people and their environment are 
primarily in the form of information exchange" (p. 1097) 
For people coping with the stress of a life-threatening 
illness the transactions include the patient, the illness 
and the environment. Due to the changes in life styles that 
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add to the etiology of disease incidence and prevalence, and 
to the growing interest in psychosomatic illnesses and 
stress research, applications of this model in the medical 
setting have been growing. 
The stress inoculation model was developed to assist 
patients in the health care setting as a means of preparing 
them to cope with stressful medical situations. Janis 
(1983) defined stress inoculation as a procedure that 
"involves giving people realistic warnings, recommendations 
and reassurance to prepare them to cope with impending 
dangers or loss" (p. 67). This procedure of preparation can 
vary on a range of intensity from brief verbal and/or 
written instructions to a well formulated training program. 
A program inclusive of graded exposure to the stressful 
situations with skill enhancing coping strategies will help 
to reduce emotional distress and create opportunities for 
personal control. 
Interest in helping people psychologically prepare 
themselves in dangerous situations began with Janis's 
military experience in World War II. His focus was on 
reducing battle fatigue and he coined his intervention 
"battle inoculation," later changed to "stress inoculation." 
An intervention for combat readiness would certainly include 
the affect of rage to off-set the paralysis of fear. People 
with HIV are "battling" an unspeakable foe and were it 
contained, rage might be an appropriate strategy for coping. 
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Janis (1983) felt that any preparatory communications 
are said to function as stress inoculation if it enables a 
person to increase his or her tolerance for subsequent 
threatening events. When successful, the process is called 
stress inoculation because it may be analogous to what 
happens when people are inoculated to produce antibodies 
that prevent disease. Strategies for living daily with HIV 
could thus be seen as psychological antibodies against the 
stressful assault of this illness. 
A growing body of literature on the diverse use of 
stress inoculation training (SIT) (Blythe & Erdale, 1986; 
Diffenbacher, 1988; Janis, 1983; Meichenbaum & Cameron, 
1983; Perry, 1991) identifies the unique and complementary 
strengths of the theoretical concepts. These include the 
rational restructuring and systematic desensitization 
interface of cognitive and behavioral therapy. The stress 
inoculation model is based on a collaborative effort in the 
cognitive reframing and reconstructing of the problem toward 
solutions that promote personal control and adaptive coping. 
Meichenbaum and Cameron's (1983) general stress 
inoculation training paradigm was developed as a skills 
training approach to anxiety management. Their paradigm 
contains three phases - educational, skills training, and 
application - that with modification can be applied to HIV 
seropositive patients in their pre-AIDS stage of disease: 
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Education/Conceptualization 
1) begin to restructure and reframe cognitive schema of 
the HIV virus on a continuum creating hope. 
2) break down the stressors of the disease into 
specific behaviors and reactions. 
3) educate the patient and significant other on the 
nature and impact of stress. 
4) challenge myths about alternative treatments with 
more realistic expectations that allow for strategies 
for healthy life styles and adaptation. 
5) educate on legal and community resources that 
promote personal control and empowerment. 
Skills Acquisition 
1) explore current coping and how it affects the 
current situations. 
2) provide problem-solving skills directed at 
modification, avoidance and minimization of "triggers" 
that produce stress. 
3) palliative coping for dealing with uncertainty, 
i.e., self-talk, passive relaxation training. 
Application and Rehearsal 
1) preparation of use of coping skills through 
discussion of disclosure, employment dialogue, and 
physician visits with behavioral rehearsal. 
2) use of graded exposure with HIV slides and 
discussion materials from physician and nurse 
3) homework which might include self-talk phrases, 
relaxation techniques, journals. 
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Janis's (1983) use of stress inoculation on surgical 
patients indicated that preparatory information can 
inoculate people to withstand the disruptive and emotional 
reactions to surgery. In his review of other medical uses, 
he found this technique does not apply to all situations and 
the success of inoculation attempts will vary depending on 
the nature of the stress. Another recognized success of 
preparatory training is seen in the widely used Lamaze 
technique for childbirth. 
Diffenbacher (1988) felt that "the best treatment fit 
would be to match the characteristics of the intervention to 
the most salient aspects of the patient's anxiety" (p. 94). 
Clearly, the need exists for expansion of clinical 
interventions in reducing the emotional stress of HIV in the 
medical setting, especially methods of preparation that help 
manage the deleterious effects of the physical, 
psychological, and social impact of this disease. 
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SUMMARY 
The first two sections of the literature review 
provides a description of the illness and the emotional 
distress felt by HIV affected individuals in the early 
stages. The last section provides an integrative approach 
for stress reduction through a model that promotes personal 
control and empowerment. The goal of understanding the HIV 
disease is not a static event, but an on-going process that 
begins at the earliest contact and continues as the symptoms 
and disease progress. 
CHAPTER III 
METHODOLOGY AND PROCEDURES 
When we listen, we forget; 
When we read, we remember; 
When we do, we understand. 
Chinese Proverb 
INTRODUCTION 
This field research experiment was shaped by the true 
experimental design with its elements of pretest-posttest, 
randomization, and comparison groups. The combined 
characteristics of this design were ideal for providing 
evidence for a cause and effect relationship between 
variables (Yegides & Weinbach, 1991) . The rigorous controls 
for validity have made this the most widely used of the 
experimental designs (Campbell & Stanley, 1963). 
This study was designed to test the effectiveness of a 
biopsychosocial educational program entitled "Living with 
HIV" which was based on a cognitive-behavioral approach 
utilizing the "stress inoculation model." It was developed 
as an intervention for stress reduction and survival for 
people battling the HIV disease in the pre-AIDS stage. 
Patients living with the stress created by this 
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life-threatening illness need help navigating the maze of 
medical, legal, emotional and social reactions they 
experience daily. This program provides strategies as a 
first line of defense in training individuals to anticipate, 
prevent and cope with the emotional distress of being 
HIV-infected. 
METHODOLOGY OF THE STUDY 
This study examined the dependent variables of 
depression, anxiety, internal health locus of control, and 
medical compliance, against the independent variable a 
biopsychosocial educational program. The study subjects 
were randomized between experimental or control groups and 
participated in the pre-and-post assessment scales. 
INDEPENDENT VARIABLE 
"Living with HIV" is a model developed for this study. 
Its content is based on the major biopsychosocial issues 
identified through clinical observations in the early stages 
from a medical, social, legal and psychological perspective. 
This program was facilitated by a clinical social worker and 
included speakers from both the clinic and community. This 
interdisciplinary group included an infectious disease 
physician, psychiatrist, clinical nurse specialist, social 
worker, nutritionist, lawyer, and a representative from the 
Social Security Administration. The goals of the program 
were threefold: 
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1. Promote medical education, medical compliance and 
risk reduction behaviors. 
2. Enable patients to exercise more control over 
their health by becoming informed consumers of 
health care issues and services while forming 
decision-making partnerships with their Health 
Care Team. 
3. Provide skill enhancing techniques for adaptive 
coping and reduction of emotional distress. 
This program utilized the stress inoculation model of 
preparation for future threatening events and was balanced 
with a supportive relationship with the health care team, 
significant others, and community. The agenda for the six 
weekly sessions of ninety minutes per session consisted of 
the following: 
SESSION 1. Introduction to "Living With HIV" Program 
A. Program Overview 
Speaker: Social Worker 
1. Goals, Purpose and Methods 
2. Confidentiality 
3. Resource Packets 
B. Introduction to the HIV Clinic 
Speaker: Clinical Nurse Specialist 
1. Overview of Clinic Structure and Operations 
2. Clarification of Clinic Services 
3. Nursing Role in Clinic Services 
4. National Clinical Trial Center 
5. HIV Service Team Inpatient Defined 
SESSION 2. Medical Management of HIV Disease 
A. Introduction to HIV Health Issues 
Speaker: Infectious Disease Physician 
1. Promoting a Partnership in Health Care 
Treatment Decisions 
2. HIV 101 - Basic Knowledge 
3. Primary and Secondary Prevention 
4. Interpreting Laboratory Results 
5. Strategies for Healthy Lifestyles 




2. Nutrition and Immune Function 





C. Strategies For Improving Nutritional Status 
1. Normal Nutrition 
2. The Role of Each Nutrient 
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3. Water, Vitamins and Minerals 
4. Special Considerations 
5. Supplements 
6. Ways to Increase Calories /Protein 
7. Food Safety, Drug-Nutrient Interactions 
8. Alternative Therapies 
D. Activity Table 
1. Food Recall and Pyramid 
2. Supplement Tasting 
3. Food Safety Quiz 
SESSION 4. Legal Issues I Social Security 
A. HIV Legal Issues 
Speaker: Lawyer/AIDS Legal Council 
1. Discrimination Laws: ADA 
2. Confidentiality Laws 
3. Power-of-Attorney: Health & Property 
4. Estate Planning 
B. Social Security Entitlements 
Speaker: Social Security Representative 
1. Review of benefits -Title II, SSA and SSI 
2. Eligibility Criteria 
3. Process of Claims and Appeal 
SESSION S. Resources for Empowerment 
A. Health Insurance 
Speaker: Clinical Social Worker 
1. Understanding Managed Care: Traditional, HMO, 
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PPO, POS, Self Insured and Individual Policies 
2. Understanding your Medical Coverage 
3. Federal and State Insurance Coverage Medicare, 
Medicaid and ICHIP 
4. Cobra Laws - 18 Months vs 29 Months 
Ryan White Funds - ICHIC 
B. Additional Resources 
1. Federal Drug Reimbursement Program 
2. Compassionate Use Programs 
SESSION 6. Handling Feelings and Stress 
Speaker: Psychiatrist 
A. Identifying Stress 
1. Predisposition to Stress 
2. Coping with feelings and defenses 
3. Common Emotional Concerns 
4. Getting Help for Stress 
B. Techniques for Stress Management 
Speakers: Psychiatrist/Clinical Social Worker 
1. Relaxation and Imagery 
2. Self-Statements to Enhance Coping 
3. Strategies for Living Daily with HIV 
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The sessions concluded with a review of some of the 
strategies for living daily with HIV with encouragement for 
participants to continue to build upon these for 
self-enhancement and empowerment (See Appendix C) In 
addition, a Program Evaluation was completed by those in 
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attendance at the last session (See Appendix C) . 
SAMPLE 
The sample for this study consisted of nineteen (N=19) 
HIV seropositive adult patients registered with the 
Comprehensive HIV Clinic within a hospital setting. 
Eligibility for the study required that patients be 
diagnosed in the early stage of the HIV disease by their 
physician and be new to the clinic within the past six 
months. Other criteria for inclusion were: 1) CD4 (T-helper 
cell) count of greater than 200; 2) no evidence of 
opportunistic infections that define progression to AIDS; 
and 3) patients with a history of chemical dependency must 
have been in recovery for a period of three years. 
This clinic population of adults at risk for HIV 
disease was representative of national norms with a majority 
of the patients being homosexual but with increasing numbers 
of intravenous drug users and women. A smaller number of 
hemophiliac patients completed the risk groups in the 
clinic. Patients seek medical interventions at various 
points on the clinical HIV continuum from those newly 
diagnosed and asymptomatic to those further progressed and 
symptomatic, to those with full-blown AIDS. 
Recruitment for the study involved the posting of 
notices defining the study and its criteria at the clinic 
reception desk and the patient waiting room. In addition, 
52 
physicians informed those patients who were eligible about 
the study during their clinic visits. Discussing research 
protocols with patients was standard practice at this clinic 
due to the clinic's participation as a national clinical 
trial site. 
Unfortunately, at the time of recruitment the clinic 
experienced a majority of new patients further progressed in 
their illness leaving a smaller number eligible for this 
study. The nature of the disease with its high element of 
uncertainty and unpredictability, along with the 
individual's idiosyncratic response to the virus and medical 
intervention, resulted in diagnostic changes from a pre-AIDS 
status to AIDS. Therefore, in an attempt to maintain 
criteria for inclusion in the study, the time frame for 
measuring the efficacy of the independent variable was set 
to five months. 
Initially, 22 subjects agreed to participate, giving 
eleven (N=ll) in the experimental group and eleven (N=ll) in 
the control group. However, one subject (female) in the 
experimental group attended only one session and was then 
lost to follow-up after repeated attempts to make contact. 
Additional adjustments to the sample were made at the 
post-test period of time due to further attrition of two 
subjects (males) in the control group. One subject had 
moved out-of-town and the other was lost to follow-up. 
Again, numerous attempts to contact them were made without 
response. Of the three subjects, two were less than 35 
years old, and two had less than 500 CD4 counts. 
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Furthermore, two subjects in the experimental group had 
completed both the pre and post tests but didn't attend any 
sessions; they became part of the control group. This left 
a final sample configuration of eight (8) in the 
experimental group and eleven (11) in the control group for 
a total of nineteen (N=19) study subjects. 
CONFIDENTIALITY 
A major ethical concern when conducting research was 
the protection of the individual's confidentiality regarding 
their participation and response in a research project. 
From the beginning of the HIV crisis scientific research in 
the form of clinical trials had been the main source of 
medical intervention for HIV-infected people. The social and 
legal risks involved with this population in research had 
created state and federal laws for their protection. In 
addition, professional disciplines carried their own 
standards of ethical practice. 
To protect the confidentiality of those in the study, 
the following steps were taken. All subjects were given a 
code number after agreeing to participate in the study. 
Their code numbers, along with their name, social security 
number and telephone numbers, were kept on a master list and 
locked in a confidential location and destroyed at the end 
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of the study. Personal information was needed for contact 
for pre and post test appointments as well as medical chart 
review for three months following the posttesting. 
For those randomized to the program, first names only 
were used. Participants and their guests signed their first 
names on name tags used throughout the program. Finally, 
subjects were reassured that none of the research data would 
be included in their medical charts. 
Ethical and moral considerations for research with 
human subjects in a hospital setting carried strict 
requirements and guidelines for conducting this study. Of 
major importance were concerns for confidentiality and for 
the methodological steps to be taken to protect other 
patient rights. Applications for this project were 
submitted in a required format and processed by three 
separate offices. First, the University's Office for the 
Protection of Research Subjects Institutional Review Board 
gave its approval for the use of human subjects for research 
purposes. Second, the Research Office and Research 
Committee of the hospital gave their approval for both 
scientific and administrative use. And thirdly, approval 
for this study was also sought and approved by the 
Institutional Review Board at Loyola University of Chicago 
(see Appendix E) . 
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SETTING 
The setting was in a large medical teaching center in 
its Comprehensive HIV Clinic (CHC) in a major midwestern 
city. This Clinic offered primary care and was a national 
clinical trial site with approximately 600 patient visits 
per month. The medical care was managed by a 
interdisciplinary staff which included infectious disease 
physicians, post doctorate fellows, psychiatrists, nurses, 
social workers, a dietitian, a respiratory therapist, and a 
phlebotomist. In addition, consultation services were also 
available in the Clinic from an oncologist, neurologist and 
ophthalmologist. Appointments for the study interviews 
often coincided with clinic visits or work schedules and 
were held in the Clinic in private rooms to insure 
confidentiality. The study program "Living with HIV" was 
also held in the clinic conference room to accommodate 
participants and their guests. 
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INSTRUMENTS 
The process of quantifying the dependent variables for 
this study involved both self-report and observer rated 
instruments. Hamilton (1976) advocated for the observer 
rated process over the self-report. He felt it had 
theoretical advantages as observers were more likely to 
"penetrate the mask which patients tended to use to hide 
their symptoms" (p. 58). Corcoran and Fischer (1987) 
reported that quantification was beneficial in work with 
patients because it allowed you to monitor change 
mathematically. It was this presentation of change scores 
that created the interpretive process for clinical 
significance. 
The purpose of this study was to examine the 
effectiveness of the program (independent variable) 
comparing the experimental and control groups in a 
measurement of change scores over time. Seven instruments 
were utilized beginning with the descriptive demographic 
data collected from the subjects and their medical records 
that included: sex, age, ethnicity, marital/partner status, 
education, employment, risk category, CD4 count and date of 
diagnosis. The psychological measurements included the 
following: 
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THE BECK DEPRESSION INVENTORY: The Beck Depression 
Inventory (BDI) (Beck, et al., 1961) was a self-administered 
21 item scale designed to measure the severity of depressive 
symptoms with four alternative statements rated from O to 3. 
It had a score range from 1-63. The conventional cutoff 
score of greater than thirteen (13) was used with other HIV 
studies (Perry, et al., 1993). This depression scale was 
subjected to numerous tests to determine its reliability and 
validity. Internal consistency between the individual 
category scores and total scores was significantly beyond 
0.001 level (Beck et al., 1961) and a split-half reliability 
coefficient (r = 0.93). 
This psychological measurement had proven its 
appropriateness over time with a high level of utility, 
sensitivity, and directness in measuring manifested 
behaviors hence its overall suitability for the context of 
this study. However, the somatic items composing a portion 
of the BDI (e.g., fatigue, appetite loss and insomnia) may 
have reflected physical disease rather than depression (See 
Appendix D) . 
THE HAMILTON DEPRESSION RATING SCALE: The Hamilton 
Depression Rating Scale (HAMD) (Hamilton, 1976) was a 17 
item scale rated on 3 to 5 point scale designed to assess 
depressive illness as a self-report or observer rated 
measurement. This study used the observer rated method 
following the 17 item Structured Interview Guide (Williams, 
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1988). This scale gave details on specific symptoms (e.g., 
suicidal ideation on items 7, 8, & 9) and identified 
different degrees of severity of depressive illness. A 
score of greater than thirteen (13) usually marked clinical 
depression. In combination with the BDI, the literature 
reported a high correlation in validity between the use of 
the two scales (HAMD=0.84; BDI=0.77) Reliability for the 
HAMD is 0.88 (See Appendix D). 
THE HAMILTON ANXIETY RATING SCALE: The Hamilton 
Anxiety Rating Scale (HAS) (Hamilton, 1969) was an observer 
rated scale consisting of 14 biological descriptions 
designed for the rating of generalized anxiety states. The 
symptoms are bipolar, splitting them into two subscales 
between psychic (7) and somatic (7) . Studies linking the 
HAS to diagnosis of generalized anxiety disorder used a 
cutoff score of greater than or equal to fourteen (14) and a 
median of twenty-five (25) for the DSM-IIIR Posttraumatic 
Stress Disorder (Beck et al., 1984; Perry et al., 1993) (See 
Appendix D) . 
THE IMPACT OF EVENT SCALE: In The Impact of Event 
Scale (IES) (Horowitz, Wilner & Alvarez, 1979) each subject 
was asked to complete this 15 item self report instrument 
designed to measure the stress associated with traumatic 
events. The authors intentionally did not define the event, 
but left this to the observer and respondent at the point of 
instructions on use. This instrument measured two 
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categories of response to traumatic events in subscales: 
intrusive (7) experiences such as images, troubled dreams 
and waves of feelings; avoidance (8) experiences such as 
conscious awareness of avoidance of certain ideas, feelings, 
meanings and their consequences (Horowitz et al., 1979). 
A revision of this scale resulted in the current 15 
item scale with a split-half reliability of the total score 
(r=0.86). Additional internal consistency of the subscores 
using the Cronbach's Alpha indicated intrusive at 0.78 and 
avoidance at 0.82. The measure had a test-retest 
reliability of 0.87. This instrument's overall 
appropriateness included elements of utility in its use and 
scoring, suitability to the context of the population being 
studied, sensitivity to observation of change over time, and 
finally in its directness in capturing the signs of living 
daily with a life-threatening illness. Scoring for the IES 
in several recent studies had led to a selection of a score 
of twenty (20) as a cutoff for either subscale. Scores 
above twenty on either subscale were strongly predictive of 
a significant stress response and a DSM-IIIR Posttraumatic 
stress disorder (Cella et al., 1990) (See Appendix D). 
THE MULTIDIMENSIONAL HEALTH LOCUS OF CONTROL SCALES: 
The Multidimensional Health Locus of Control Scales (MHLC) 
(Wallston et al., in press) was a recent expansion of the 
MHLC referred to as Form C. It differed from Form A and B 
in that the health condition was mentioned with the 
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instructions. Inserting HIV for the word condition added 
face validity and utility to this measure. Its design was to 
measure eighteen items of patients' belief regarding control 
over their health concerns from an internal Locus of Control 
(6), from chance (6), and from powerful other that further 
divides between the physician (3) and other (3). This study 
focused only on the scores for internal, and powerful 
others, which included physician and significant other. 
This 18 item self report measure used a 6-point likert 
format ranging from strongly disagree to strongly agree 
scores. The MHLC had been revised from a unidimensional to 
a multidimensional scale improving the reliability of the 
internal consistency utilizing the Cronbach's alpha between 
0.67 to 0.77. This additional scale increased the criterion 
validity. Total scores in each category indicated the level 
of effect HIV has on the subject (See Appendix D) . 
THE MEDICAL REVIEW LOG: The Medical Review Log (MRL) 
was a form created for this study to log both the 
experimental and control groups medical compliance for a 
period of three months following completion of the 
biopsychosocial education program and posttesting. Included 
on this form were the date of review, compliance per 
participant of scheduled clinic appointments, along with 
medication (oral, intravenous or aerosol) and specialty 
compliance. The major focus for this study was the 
participants compliance with clinic appointments. The 
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appointment book and medical charts were reviewed placing a 
Y (Yes) and N (No) for indication of compliance and NA (not 
appropriate) if appointment was not scheduled. No 
information was added to the patient's chart nor shared with 
other clinic staff members (See Appendix D) . 
PROCEDURES 
Notices of the study describing its purpose and 
criteria were posted at both the reception desk and patient 
waiting room in the Clinic that included the project 
investigator's (PI) name and telephone number for contact 
(See Appendix A) . The same information about the study was 
also given to those patients who met criteria from their 
physician during their clinic appointment. At the point of 
contact further explanations of the study were given and an 
appointment for pretesting was scheduled. 
Participation in the study was voluntary and patients 
were not paid a fee. However, for those randomized to 
attend the program, the clinic provided a small grant to 
cover parking fees and light refreshments. Due to location 
and parking difficulties those subjects and guests traveling 
by car received stickers for the hospital parking facility. 
And with the time of the program in the early evening, light 
refreshments approved by the dietitian were provided. 
A master list was developed that included the code 
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number, name, social security and telephone number of each 
subject as appointments were made (See Appendix A). This 
personal information was necessary for making contact for 
scheduling pre and post testing, maintaining attendance at 
the "Living with HIV" program, and identification of medical 
charts for the three month review. This master list was 
kept in the locked desk of the PI and destroyed at the end 
of the study. Randomization for this study was by code 
numbers as appointments were made and completed. 
Individual appointments for the pretesting were made to 
accommodate the subjects' clinic or work schedule. Prior to 
data collection all subjects signed an informed consent to 
participate in the study (See Appendix B) . First the 
demographic information was obtained that included sex, age, 
ethnicity, marital/partner status, education, employment, 
risk category, CD4 count, and date of HIV+ diagnosis (See 
Appendix D). Next a set of psychological inventories, both 
self-administered and observer rated, were given in the 
following order: the Beck Depression Inventory (BDI), 
Hamilton Depression Rating Scale (HAMD), Hamilton Anxiety 
Rating Scale (HAS), Impact of Event Scale (IES) and the 
Multidimensional Health Locus of Control Scale (HLOC) (See 
Appendix D) . Total time for this process was less than 55 
minutes. 
At the completion of the pretest data collection, 
randomization between the experimental and control group was 
63 
done by code numbers. Those with odd numbers were 
experimental, and those with even numbers were control. The 
experimental group was given a schedule with the dates, 
time, and location for the program. In addition, each 
program participant was encouraged to invite up to two 
guests per session for the purpose of building support among 
their significant others. A secondary gain from such a 
program was the possible disclosure of patients' HIV medical 
situation to loved ones. Though this was not an issue being 
examined in this study, it represented an interest of the 
investigator. Those randomized to the control group were 
assured exposure to the program and informed the program 
would be repeated at the conclusion of the study and they 
and their guest would be invited to attend. In addition, 
all support services offered to clinic patients were 
available upon request. 
The experimental intervention ''Living with HIV" began 
one week after completion of the last interview. The 
importance of attending all six sessions was emphasized as a 
means of achieving the program's goals. It was expected 
that illness of the study participants might prevent 
attendance. In fact, illness was given as a reason for two 
of the participants missing the final session. However, the 
illness of the PI who was also the facilitator and speaker 
for the fifth session resulted in the group's decision to 
double up the last two sessions of Resources for Empowerment 
and Handling Feelings, rather than adding an additional 
week. Participants were asked to contact the PI if they 
were unable to attend a session or if guests were not 
attending. 
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For those unable to attend a session the PI provided 
the participant and/or guest an outline and materials 
covering the topic of discussion. Non-attendance or missing 
more than three sessions significantly detracted from the 
program goals and its possible effectiveness on outcome 
measures. Two subjects who did not attend any sessions but 
completed pre and post test were excluded from the original 
experimental group assignment and thus included in the 
control group. 
Sensitivity to the need for confidentiality of those 
attending the program was maintained by using first names 
on everyone's name tag. The program was held in the CHC 
Conference Room for comfort and to accommodate the speakers' 
audio and visual equipment needs. Resource packets with 
medical and community resources were given to each 
participant and their guests at the first session. 
Additional materials and resources from each session were 
then added to the packets. At the concluding session a 
program evaluation was available to the six subjects in 
attendance as were appointments for posttesting. Telephone 
contacts were made to all others to arrange for posttesting 
appointments. 
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At the posttest the subjects once again completed the 
psychological inventories that included: the Beck Depression 
Inventory (BDI), the Hamilton Rating Scale for Depression 
(HAMD), the Hamilton Anxiety Rating Scale (HAS), the Impact 
of Events Scale (IES) and Multidimensional Health Locus of 
Control Scales (HLOC) . The average time frame for 
completing the posttest was less than 45 minutes. At the 
conclusion of the assessments, any comments given by the 
subjects about the materials and/or program in addition to 
the evaluation were noted. The control group was informed 
of the next scheduled "Living with HIV" program and invited 
to participate. This was scheduled after the chart reviews. 
The three month medical chart review began at the 
conclusion of the posttest. This study was assessing the 
medical compliance of all study subjects based on adherence 
to their clinic appointments. Patients' were given medical 
appointments based on their individual medical condition 
and CD4 count, recognizing that not everyone was scheduled 
on a monthly basis. The Medical Review Log indicated 
compliance for scheduled appointments. It also looked at 
agreed upon medications and specialty referrals. 
Information was obtained from the patients' medical 
records verified by name and social security number kept in 
the CHC record room. The physicians procedure notes were 
gleaned for compliance during the three month period of 
time. A clinic procedure for recording missed appointments 
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was a stamped notice in the medical charts, which provided 
attendance information for the study. All compliance 
information was noted on the Medical Review Log (See 
Appendix D) developed for this study by placing a Y (Yes) or 
N (No) or NA (Not Applicable) beside each category for each 
participant for three months. 
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RESEARCH HYPOTHESES 
This study was designed to examine the effectiveness of 
a stress inoculation model to reduce emotional distress for 
HIV-infected people in their pre-AIDS stage through the four 
hypotheses listed below. 
Hypothesis 1: Participation in a biopsychosocial 
educational program will result in a decrease in 
anxiety in the experimental group compared to the 
control group. 
Hypothesis 2: Participation in a biopsychosocial 
educational program will result in a decrease in 
the mood disturbance of depression in the 
experimental group compared to the control group. 
Hypothesis 3: The experimental group will show 
increased levels of locus of internal control 
versus physicians' and others' control as a result 
of their participation in the biopsychosocial 
educational program in comparison to the control 
group. 
Hypothesis 4: Participation in a biopsychosocial 
educational program will result in an increase in 
medical compliance among the experimental group 
compared to the control group for a period of 
three months following the completion of the 
program. 
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DATA ANALYSIS AND INTERPRETATIONS 
Descriptive and inferential statistics were used in the 
analysis of the demographic data and the four research 
hypotheses for this study. To begin with, it was customary 
to compile and present a summary description of the 
characteristics of the research sample into group form 
(Yegides & Weinbach, 1991) . The descriptive analysis began 
with frequency tables by total sample then by groups to 
provide demographic differences and similarities of the 
sample under study. The Fisher's Exact Test of Association 
for small samples was utilized. Summation of the demographic 
characteristics further defined the sample participants in 
this study. 
Inferential statistics were used to analyze the four 
study hypotheses utilizing the raw scores from the 
assessment instruments. The analysis focused on the pretest 
versus posttest change scores between the experimental group 
compared to the control group. The most widely used 
acceptable test for looking at change scores was the t test 
with the analysis of covariance to level the pretest score 
(Campbell & Stanley, 1963). This study utilized the 
parametric t test for small samples with equal-interval 
data. The student's t test of significance began with the 
measurements of differences on assessment scales within the 
groups utilizing the correlated paired t test for dependent 
samples. This measured whether the differences from 
prescores to postscores within the experimental group and 
within the control group were different from zero. 
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The second application of the t test was to test the 
differences between groups utilizing the pooled t test for 
an independent two sample case. This procedure provided two 
separate comparisons to consider. The first compares 
differences between groups in their mean change from 
postscores minus the prescores. The second procedure 
compared differences in mean change of the experimental 
versus control groups for pre scores, or post scores. 
Finally, an analysis of covariance (ANCOVA) permitted 
"a post-hoc, statistical control for one or more concomitant 
variables, removing their influence from the comparison of 
groups on the experiment factor" (Hays, 1994, p. 811). This 
statistical procedure was a way of testing the effect of the 
research experiment by adjusting for any equality of the 
prescore values. This study used the SAS System for Linear 
Models computer package. 
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LIMITATIONS OF THE STUDY 
Inherent in all research studies is the awareness of 
limitations that affect the generalizability of its results. 
This study was no exception with limitations that involved: 
1) a smaller sample size meeting criteria during 
recruitment, 2) adjustment to the "Living with HIV" program 
schedule, 3) sample attrition and adjustments to the size 
and group configuration, 4) attendance at the program, and 
5) intervening effects of changes in the subjects' medical 
status and the influence of others. 
The study experiment was dependent on the program 
content, materials, order of presentations and the abilities 
of the speakers to promote coping, adaptation and 
empowerment. Assessing the impact on change scores as a 
result of the independent variable for this population 
raised limitations on outcome results. For it was 
recognized that the media impact in reporting scientific 
failure, concerns over health care coverage, and the 
stigmatization of the HIV-infected populations during this 
time could not be controlled for its effects on outcome 
measurement. In addition, the idiosyncratic responses of 
the study subjects to their level of infection during the 
program suggested further implications for changes in 
emotional distress. 
The ability to assess emotional distress within this 
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population at this stage of adjustment recognized a 
limitation to the study methods. Ongoing efforts to manage 
anxiety and depressive symptoms through medications external 
to the study were not identified or accounted for in this 
study. Though it might not have been a reason for exclusion 
for the purposes of this study, this undoubtedly would have 
added insight to the outcome data. 
Such limitations did not diminish the importance of 
this biopsychosocial intervention as a vehicle for coping 
and surviving for HIV-infected people in the earlier stage 
of the disease. It further encourages replication that is 
content appropriate for the setting, population and stage of 
the illness. 
CHAPTER IV 
PRESENTATION AND ANALYSIS OF DATA 
"Whether reducing distress or decreasing the risk of 
suicide is meaningful is a matter of values. By the 
same token, defining the minimum amount of change 
necessary to be meaningful is also a matter of values" 
(Hollon & Flick, 1988, p. 203). 
INTRODUCTION 
The purpose of this chapter was to report the results 
of the investigation of the effectiveness of the independent 
variable ''Living with HIV", a biopsychosocial educational 
program. The study findings for this chapter were divided 
into three sections: 1) descriptive data, with subject 
characteristics and frequency findings, 2) inferential 
statistics, analysis using the t test, and 3) subjective 
responses, participants' feedback on the study. 
The quantitative findings for this study were generated 
in three distinct time periods. The first time period 
yielded the data collection of the demographic information 
followed by the pretest psychological assessments scales. 
These scales were designed to measure depression, anxiety, 
impact of the event of HIV disease and health locus of 
control. Subjects were asked to respond to the assessment 
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questions based on their feelings and experiences from the 
past seven days. The instruments included the Beck 
Depression Inventory (BDI), the Hamilton Depression Rating 
Scale (HAMD), the Hamilton Anxiety Rating Scale (HAS), the 
Impact of Event Scale (IES), and the Health Locus of Control 
Scale (Form C) (HLOC) . All participants completed the 
scales. 
The second time period began at the completion of the 
study intervention that consisted of a six week 
biopsychosocial educational program entitled "Living with 
HIV". This program began in January and was completed in 
February, 1994. At the conclusion of the program, nineteen 
participants were again administered the same five 
assessment scales as a post-test measurement. The third 
time period began at the completion of the post-test and 
involved a three month medical chart review to assess the 
participants' medical compliance. Charting of study 
compliance measurements were made on a form created for this 
study called a Medical Review Log. 
The subjective response of the participants to the 
study experience was generated at the completion of the 
study. The experimental group was asked to complete a 
program evaluation on the last night of the program. Six 
participants attended and completed the evaluation. 
Responses are reported here, however, any clinical 
significance this might add is presented in the next chapter 
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on discussion and implications of the study. 
DESCRIPTIVE DATA AND ANALYSIS 
Demographic information was collected on all 19 
subjects at the pretest time period that included sex, age, 
ethnicity, marital/partner status, education, employment, 
risk factor, CD4 count, and time of diagnosis. The 
following presentation and charts are a descriptive analysis 
of the demographic characteristics of the sample. 
SUBJECT CHARACTERISTICS 
The sample's age ranged from 25 to 46 years, with a 
mean age of 34.4 (SD= 6.14). Sixteen percent (N=3) were in 
their twenties, sixty-three percent (N=l2) in their thirties 
and twenty-one (N=4) in their forties (See Figure 1). 
The majority of the sample were men, eighty-four 
percent (N=l6), which is consistent with national norms for 
this disease. Sixteen percent (N=3) were female. The 
ethnicity of the sample consisted of sixty-eight percent 
(N=l3) Caucasians, twenty-one percent (N=4) African-American 
and eleven percent (N=2) Hispanic (See Figure 2) . 
Educational achievement was evident in this sample with 
a median education level of 16, which represents a college 
degree (range 12-19 years) . Twenty-six percent (N=5) 
completed their education with their high school diploma. 
FIGURE 1: AGE 
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Ten percent (N=2) had at least two years of college and ten 
percent (N=2) had completed three years of college. Further 
education consisted of thirty-three percent (N=6) who 
completed a college degree. And twenty-one percent (N=4) 
achieved graduate degrees with two at the masters level and 
two doctorate of law degrees (See Figure 3). 
A majority of the sample reported they were employed 
with seventy-four percent (N=l4) working full-time, ten 
percent (N=2) as part-time and sixteen percent (N=3) as 
unemployed. Of those unemployed, one was a housewife and 
one was a full-time graduate student. 
In terms of marital/partner status, seventy-four 
percent (N=l4) defined themselves as single. Eleven percent 
(N=2) were married, and eleven percent (N=2) had live-in-
partners. And four percent (N=l) were widowed. In terms of 
risk factors for HIV, eighty-four percent (N=l6) reported 
their risk factor as homosexual, again meeting national 
norms as the major risk group. Sixteen percent (N=3) 
reported heterosexual contact as their risk factor (See 
Figure 4). 
Normal CD4 (T-helper cells) counts for healthy 
individuals was 1000, with a plus or minus 500. The CD4 
count was a direct measure of the immunologic status of 
HIV-infected individuals and was considered the most 
important marker of the disease progression. Since the CD4 
count declined during the course of illness, antiretroviral 




















therapy was now suggested to patients with a CD4 count of 
less than 500. With less than a 200 CD4 count, therapy to 
prevent or control pneumocystic carinii pneumonia was 
initiated. 
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At the time of the data collection the samples' CD4 
(T-helper cells) counts were as follows: twenty-one percent 
(N=4) were between 201-300; thirty-two percent (N=6) were 
between 301-400; twenty-one percent (N=4) were between 
401-500; ten percent (N=2) were between 501-600; and sixteen 
percent (N=3) had greater than 601 CD4 counts (See Figure 5) 
Finally, HIV seropositive people entered the medical 
system at different stages on the HIV continuum due to a 
variety of factors. Among these factors were delayed 
testing, change in medical services or denial. The 
following variability in the time since diagnosis in this 
sample supported this view: fifty-eight percent (N=ll) had 
been diagnosed less than a year; eleven percent (N=2) 
diagnosed one to two years; eleven percent (N=2) diagnosed 
three to four years; sixteen percent (N=3) diagnosed five to 
six years; and four percent (N=l) diagnosed more than six 
years (See Figure 6) . 
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FIGURE 6: TIME OF 
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The demographic characteristics were divided into a 2x2 
contingency table for evidence of association with the 
Fisher's Exact Test for small samples. They are presented 
first from a total sample perspective (see Table 1), 
followed by experimental and control group (see Table 2). 
The findings provided evidence of significant differences 
between groups at the p < .05 and p < .07 levels. 
These demographic findings suggested some divergent 
patterns between the experimental and control groups. An 
example of differences was seen with age, education, CD4 
count and the time of diagnosis. For instance, comparing 
those under 35 to those over 35 years old, the experimental 
group had seventy-five percent (N=6) under and twenty-five 
percent (N=2) over the age of 35. This compared to the 
control group with forty-five percent (N=5) under and 
fifty-five percent (N=6) over 35. Fisher's exact two-tail 
test was 0.352 significant at p < .05 . 
The educational level was divided for this sample 
between low education (high school plus some college) and 
high education (college plus) . The experimental group had 
thirty-eight percent (N=3) low and sixty-two percent (N=5) 
high. This compared to the control group with fifty-five 
(N=6) low and forty-five (N=5) for high resulting in a 
Fisher's Exact Test of 0.650 (two-tail test) at p < .07. 
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TABLE 1. SAMPLE DEMOGRAPHIC FREQUENCIES 
Sample Characteristics N % 
SEX Male 16 84 
Female 3 16 
AGE less than 35 11 58 
greater than 35 8 42 
ETHN Cauc 13 68 
Other 6 32 
M/P Single 14 74 
Other 5 26 
EDUC Low 9 47 
High 10 53 
EMPLOY Full 14 74 
Other 5 26 
RISK Gay 16 84 
Other 3 16 
CD4 less than 500 14 74 
greater than 500 5 26 
TOD less than 1 Year 11 58 
greater than 1 Year 8 42 
M/P Marital Partner 
TOD Time of Diagnosis 
CD4 T-Helper Cells 
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TABLE 2. DEMOGRAPHIC FREQUENCIES BY RANDOMIZED GROUPS 
Characteristics Experimental Control 
n % n % 
SEX Male 7 88 9 82 
Female 1 12 2 18 
AGE less 35 6 75 5 45* 
greater 35 2 25 6 55 
ETHN Cauc 4 50 9 82 
Other 4 50 2 18 
M/P Single 8 100 6 55 
Other 0 0 5 45 
EDUC Low 3 38 6 55 
High 5 62 5 45* 
EMPLOY Full 6 75 8 73 
Other 2 25 3 27 
RISK Gay 7 88 9 82 
Other 1 12 2 18 
CD4 less 500 8 100 6 55* 
greater 500 0 0 5 45 
TOD less 1 Yr 7 88 4 36* 
greater 1 Yr 1 12 7 64 
Fisher's Exact Test 
*Significant at ~ < .05 - group differences 
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The CD4 (T-Helper cells) count was divided between less 
than 500 or over 500 CD4 counts. The experimental group had 
100 percent (N=8) under 500, compared to the control group 
which had fifty-five percent (N=6) under and forty-five 
percent (N=5) over 500. Results of the Fisher's Exact Test 
of 0.045 (two-tail test) was significant at p < .05. 
Finally, the time of diagnosis was divided between 
those diagnosed less than a year and those greater than a 
year. A significant difference was seen with eighty-eight 
percent (N=7) less than a year and twelve percent (N=l) 
greater than a year in the experimental group. This 
compared to the control group with thirty-six percent (N=4) 
less than a year and sixty-four (N=7) greater than a year. 
Measurement on the Fisher's Exact Test of 0.037 (two-tail 
test) was significant at p < .05. 
SUMMARY OF DESCRIPTIVE DATA 
To summarize the demographic frequency by total sample 
there were heterogenous patterns beginning with the number 
of males (84%) versus females (16%). The reported major 
risk factor was due to homosexual (84%) as against 
heterosexual (16%) partners. The ethnicity of the sample 
was caucasian (68%) and African Americans (21%) and Hispanic 
(11%) . Age was divided between those under 35 (58%) and 
those over 35 (42%) . 
The majority of the sample defined themselves as single 
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(74%) with married, partners and widowed at (26%) . Those 
working full-time (74%) were compared to part-time or not 
working at (26%) . Subjects who were diagnosed HIV positive 
less than a year (58%) were compared to those greater than a 
year (42%). And finally, at the time of the study those 
with CD4 counts of less than 500 (53%) were compared to 
those with CD4 counts greater than 500 (47%) . 
Specific demographic variables that included age, 
education, CD4 count and time of diagnosis provided 
information suggestive of sample trends. For instance, the 
experimental group was younger (75% vs 45%), had higher 
educated members (62% vs 45%), had a lower CD4 count at the 
time of the study (100% vs 55%) and finally, had been 
diagnosed HIV positive within a shorter time period of less 
than a year (88% vs 36%) than the control group. The 
possible influence these sample trends had on the outcome 
data has yet to be established. 
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INFERENTIAL STATISTICS 
Four hypotheses provided focus for this study. These 
hypotheses were stated in the positive form and tested for 
significance at the P < .05 level. The analysis of the four 
stated study hypotheses focused on the change scores between 
groups and within the experimental group for any reliable 
change. Measurements for change used the t-test for 
dependent and independent small samples with Analysis of 
Covariance (ANCOVA) as a statistical control. The data 
analysis begins with two tables reporting group measures of 
psychological distress. The first table reported means and 
standard deviations (see Table 3), and the second reported 
means and mean change scores (see Table 4). This was 
followed by reviewing each study hypothesis and its 
corresponding psychological assessment scores (Hypotheses 1, 
2 and 3) and the medical review log (Hypothesis 4). 
The goal of this research analysis was to test whether 
the "stress inoculation model", a model of preparation, 
could serve as a vehicle for reducing emotional distress. 
And to do so, by investigating change scores for indications 
of stress reduction and coping improvements. Recognizing 
that with a disease as threatening as HIV, change even in 
small increments improved one's quality of life. 
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TABLE 3. MEASURES OF PSYCHOLOGICAL DISTRESS BY GROUPS 
TEST EXPERIMENTAL ( 8) CONTROL (11) 
PRE POST PRE POST 
M SD M SD M SD M SD 
BDI 13.87 8.6 12.75 5.0 8.72 6.1 9.09 8.5 
HAMD 16.00* 6.8 12.00 4.7 12.81 6.7 12.45 8.6 
HAS 15.50* 7.6 15.12* 4.9 13.54 9.7 12.54 8.1 
ISEI 15.62 4.9 16.75 3.0 12.00 5.8 13.36 4.2 
ISEA 18.00 5.9 20.75* 3.4 13.63 5.3 14.36 4.4 
HLOCI 23.37 5.4 20.62 4.6 19.81 6.0 18.63 6.5 
HLOCD 14.37 4.5 14.25 4.2 13.54 4.8 13.36 4.1 
HLOCO 10.50 3.6 9.12 2.5 9.81 2.8 10.18 3.4 
*HAMD: fourteen or greater indicates depressive symptoms. 
*HAS: fourteen or greater indicates generalized anxiety. 
*ISEA: twenty or greater indicates post-traumatic stress. 
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TABLE 4. MEASURES OF PSYCHOLOGICAL DISTRESS WITH CHANGE 










































* Paired t-test at -2.29 ( one-tail test), P < .05. 
**HAMD: fourteen or greater indicates depressive symptoms. 
Change score = post score minus pre score. 
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STUDY HYPOTHESES 
In this subsection the results of the hypotheses 
testing are reported. To measure change over time, the 
correlated t-test and pooled t-test with the statistical 
control of ANCOVA were used. Level of significance was set 
at P < .05. 
Hypothesis 1: Participation in the biopsychosocial 
educational program ''Living with HIV" will result in a 
decrease in anxiety in the experimental group compared 
to the control group. 
Measuring anxiety as a reaction to stress was obtained 
from two scales, the Hamilton Anxiety Rating Scale (HAS) and 
the Impact of Event Scale (IES). The Structured Interview 
Guide (Sigh-AD) was utilized in the administering of the 
HAS, an observer rated scale for this study. The potential 
range in score was 0-56 with the cut-off score of fourteen 
(14) for generalized anxiety disorder and a median of 
twenty-five (25) for the DSM III-R Posttraumatic Stress 
Syndrome. A higher score indicated higher anxiety. 
Table 5 presents the HAS means distribution by sample 
and by group. By sample, fifty-three percent (N=lO) met the 
criteria for generalized anxiety disorder in both pre and 
post test with fifty percent (N=4) in the experimental group 
and fifty-five percent (N=6) in the control group. The data 
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for the experimental group reported a higher level of 
anxiety than the control group with only a slight decline in 
the postscore. Their scores on both pre and post scales 
were above the cut-off of fourteen and highly suggestive of 
the diagnosis of generalized anxiety disorder during the 
study. Two of these subjects had positive change scores 
with decreases in their anxiety scores (20-14; 23-12). One 
participant showed an increase in anxiety state with an 
increased score (13-19). Scores for the control group for 
both pre and post tests were below the cut-off score of 
fourteen. They showed a slight decline in the post-test. 
TABLE 5. DISTRIBUTION OF GROUP MEAN SCORES ON THE HAMILTON 
ANXIETY SCALE 
PRE TEST POST TEST 
Range Mean SD Range Mean SD 
ALL (N=l9) 1-36 14.36* 8.78 0-25 13.63 6.90 
EXPERIMENTAL 4-27 15.50* 7.67 9-25 15.12* 4.90 
CONTROL 1-36 13.54 9.79 0-23 12.54 8.10 
* HAS: score of fourteen or greater indicates generalized 
anxiety disorder. 
Analysis of the correlated t-test (t=-0.160) within the 
experimental group and the pooled t-test (t=0.193) between 
groups was not statistically significant. This supported 
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the null hypothesis that there was no decrease in activity 
between the experimental group compared to the control 
group. The ANCOVA statistical control found no differences 
in mean values after adjusting for the HAS prescore. 
The HAS assessment for Posttraumatic Stress Syndrome 
using the median score of twenty-five (25) found the sample 
(N=l9) with a 15.00 for both pre and post scores. The 
control group had a median prescore of 15.00 and a postscore 
of 16.00 with an increase of 1.0. The experimental group 
had a median prescore of 15.00 and a postscore of 14.50 
showing a decrease of -0.50. Scores by groups did not meet 
the criteria for Posttraumatic Stress Disorder, but did so 
by two individual scores. One (13%) in the experimental 
group had a prescore of twenty-seven, and a postscore of 
twenty-five. And one (9%) in the control group had a 
prescore of thirty-six and declined to eighteen in the 
postscore. Both subjects' scores are suggestive of the DSM 
III-R diagnosis for Posttraumatic Stress Syndrome during the 
study. 
Table 6 provided a second look at the HAS but through a 
modified version of this bipolar scale. Here the scale 
allowed a measurement of the psychic features separate from 
the somatic symptoms. Of interest were postscores of the 
experimental group indicating change in the cognitive 
reframing of events as promoted with the stress inoculation 
model. After eliminating items under the somatic subscale 
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that could be present because of the direct physiological 
effects of HIV infection, i.e., genitourinary, 
gastrointestinal, autonomic, cardiovascular, and respiratory 
symptoms, a seven item psychological subscale was left. It 
had a rating of 0-4 per item with a possible range of scores 
from 0-24. The subscale for psychic features included 
anxious mood, tension, fears, insomnia, cognitive, depressed 
mood, and behavior during the interview. The following 
table displays the postscores of the subscale that included 
both psychic and somatic features for comparisons. 
TABLE 6. SCORES, MEANS AND STANDARD DEVIATIONS FOR HAS POST 
SUBS CALES 
EXPERIMENTAL (N=8) CONTROL (N=ll) 
Score Mean SD Score Mean SD 
PSYCHIC 93 11.62* 3.50 94 8.54 5.50 
SOMATIC 25 4.16 1.72 51 5.10 3.20 
*pooled t-test (t = -1.394 one-tailed test) p < .05 
Table 6 outcome data did not provide enough evidence to 
show the experimental group had less anxiety than the 
control group using the modified HAS. Psychological 
distress rather than somatic disturbances of the HAS 
appeared to represent the major response for this 
HIV-infected sample. This was particularly evident in the 
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experimental group where tension was rated highest with 
feelings of restlessness, startled response and easily moved 
to tears as most identifiable to their experiences. 
The Impact of Event Scale (IES) was a fifteen (15) item 
self-report scale developed to assess the subjective impact 
of a stressful life event. The scale was recognized for its 
sensitivity to detect change in clinical status over time. 
The items were divided into subscales with seven (7) 
intrusion and eight (8) avoidance items. It had a response 
choice of: Not at all, Rarely, Sometimes, and Often, with a 
range in score from 1-60. Being HIV-infected was the 
defining stressful life event appropriately inserted for 
this study at the point of assessment. A score above twenty 
(20) on either subscale on the IES was strongly predictive 
of a significant stress response and a DSM III-R 
Posttraumatic Stress Syndrome diagnosis. 
Table 7 presents the score range, mean and standard 
deviation of the pre and post scores for the two items of 
intrusion and avoidance by group. Again, the data suggested 
a higher stress response in the experimental group compared 
to the control group. The experimental group showed a 
broader range in scores and a higher level of intrusion and 
avoidance in their reported subjective responses. The 
experimental group had five (63%) and the control group had 
six (55%) subjects above the cut-off in at least one 
subscale for the pre and post scores. For both groups, 
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avoidance maneuvers scored higher than intrusive thoughts. 
TABLE 7. MEANS AND STANDARD DEVIATIONS FOR GROUP IMPACT OF 
EVENT SCALE 
EXPERIMENTAL (N=8) 
RANGE MEAN SD 
INTRUSION/PRE 9-24 15.60 4.9 
INTRUSION/POST 12-21 16.70 3.0 
AVOIDANCE/PRE 8-26 18.00 5.9 
AVOIDANCE/POST 17-26 20.75* 3.4 
* t= 3.38 (one-tail test), p < .05 














The correlated t-test to assess differences within the 
group was not significant. However, the pooled t-test to 
assess differences between the groups was significant in the 
post avoidance. When applying the analysis of covariance 
control an increase in mean values of avoidance in the 
experimental group was again significant after adjusting for 
the pretest. Increases instead of the anticipated decreases 
in stress response were found in the experimental group. 
The study hypothesis was attempting to replicate the 
stress response theory with an oscillating declining pattern 
between intrusive thoughts met with avoidance maneuvers in a 
downward spiralling effect. The data indicated the opposite 
for both groups with increasing intrusive thoughts met with 
94 
increased avoidance maneuvers. For the experimental group, 
the level of avoidance was more intense in comparison to the 
level of intrusive thoughts. 
Data on the HAS, the modified HAS and the IES scales 
appeared to indicate the groups were more alike than 
different. The mean scores for the experimental gr~up 
tended to display higher levels of anxiety and stress 
compared to the control group. The hypothesis for decreased 
anxiety in the experimental group attending the "Living with 
HIV" program compared to the control group was not supported 
by the outcome data. 
Hypothesis 2: Participation in the biopsychosocial 
educational program "Living with HIV" will result in a 
decrease in the mood disturbance of depression in the 
experimental group compared to the control. 
Once again two scales were used to measure mood 
disturbance, the Beck Depression Inventory (BDI) that was 
self-administered and the Hamilton Depression Rating Scale 
(HAMD) that was observer rated. The BDI is a self-
administered twenty-one (21) item scale designed to measure 
the severity of depressive symptoms. The scale has four 
alternative statements per question with a range in score 
from O to 63. The conventional cut-off score of greater 
than thirteen (13) was used to indicate the presence of 
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depressive symptoms (Perry et al., 1993). 
Table 8 presents mean scores with range and standard 
deviation by sample and group. By total sample, both pre 
and post scores were below the cut-off score for depression. 
Sixty-three percent (N=5) of subjects in the pretest in the 
experimental group, and thirty-eight percent (N=3) in the 
posttest met the criteria for the presence of depression. 
The mean change score of -1.125 indicates a decline in 
depression for the experimental group. 
TABLE 8. DISTRIBUTION OF GROUP MEAN SCORES ON THE BECK 
DEPRESSION INVENTORY SCALE 
PRE TEST 
Range Mean SD 
POST TEST 
Range Mean SD 
ALL (N=l9) 1-24 10.89 7.5 0-25 10.63 7.0 
EXPERIMENTAL 2-24 13.87 8.6 2-19 12.75 8.1 
CONTROL 1-22 8.72 6.1 0-25 9.09 8.1 
Of those meeting criteria for depression in the control 
group there were eighteen percent (N=2) in the pretest and 
forty-five percent (N=4) in the posttest. A decline in 
depressive symptoms in the experimental group was seen in 
the mean change scores between groups and within their 
group. The pooled-t-test between groups had a mean change 
score of -1.125 with P < .6360. The correlated paired 
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t-test had a mean change score of -1.125, and a P < .6658. 
The ANCOVA's were not statistically significant nor were the 
t tests. 
The Hamilton Depression Scale HAMD was a 17 item 
observer rated scale. Utilizing The Structured Interview 
Guide (Sigh-AD) the scale had a 0-1 (per 4 items), 0-2 (per 
6 items) and 0-4 (per 7 items) and a range in score between 
0-44. The scale was designed to assess depressive illness 
and gave details on specific symptoms (e.g., suicidal 
ideation 7, 8, 9 & 10) with different degrees of severity. 
A score greater than thirteen (13) usually marked clinical 
depression. Reliability for the HAMD was 0.88. In 
combination with the BDI the literature reported a high 
correlation in validity between the use of the two scales 
(HAMD=0.84; BDI=0.77) (Beck et al., 1984). 
Table 9 presents the mean scores for HAMD for the 
sample and by groups. The total sample prescore was above 
the cut-off score indicating the presence of depression, but 
the postscore showed a decline. The experimental group 
reported a higher level of depressive symptoms than the 
control group with a significant decline in the postscore. 
The correlated t-test (t= -2.29 one-tail test) within 
the experimental group was statistically significant at the 
P < .05 level. 
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TABLE 9. DISTRIBUTION OF GROUP MEAN SCORES ON THE HAMILTON 
DEPRESSION RATING SCALE 
PRE TEST 
Range Mean SD 






EXPERIMENTAL 4-22 16.00* 6.8 5-18 12.00** 4.7 
CONTROL 1-23 12.81 6.7 1-28 12.45 8.6 
* HAMD: scores fourteen or greater indicates depression. 
**t= -2.29 (one-tail test), p < .05 paired t test. 
ANCOVA between groups was not statistically significant. 
A significant decrease in depression scores indicated 
improvement for the experimental group. Their individual 
changes went from seventy-five percent (N=6) in the 
prescore to thirty-eight percent (N=3) in the postscore. 
This compared to the control group who had forty-five 
percent (N=5) in the prescore and forty-five percent (N=5) 
in the postscores. 
The use of the HAMD allowed a closer assessment of 
suicide ideation (Q 7, 8, 9, & 10), a concern supported in 
the literature for this stage of the HIV disease. The 
following is a frequency response to these questions for 
both pre and posttest scores and by groups (E = 
Experimental, C = Control): 
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Q 7. IS LIFE POINTLESS? 
PRE NO 5 ( E) 8 ( C) I YES 3 (E) 3 ( C) 
POST NO 6 (E) 9 ( C) I YES 2 (E) 2 ( C) 
Q 8. HAVE YOU THOUGHT OF ENDING IT ALL? 
PRE NO 2 (E) 7 (C) I YES 6 (E) 4 ( C) 
POST NO = 6 (E) 10 ( C) I YES 2 (E) 1 ( C) 
Q 9. HAVE YOU MADE PLANS TO KILL YOURSELF? 
PRE NO = 2 (E) 9 ( C) I YES 6 (E) 2 ( C) 
POST NO 5 (E) 11 (C) I YES 3 (E) 0 ( C) 
Q 10.HAVE YOU ATTEMPTED TO - OR DO YOU INTEND TO -
KILL YOURSELF? 
PRE NO 6 (E) 10 ( C) I YES 2 (E) 1 (C) 
POST NO 7 (E) 9 ( C) I YES 1 (E) 2 ( C) 
Those respondents who felt life was pointless did so in 
the context of their HIV diagnosis. Thoughts and plans for 
ending their lives were statements that represented attempts 
at control over future events. Their expressed fears 
focused on disease escalation and the inability to care for 
themselves; this made life seem pointless. Many referred to 
deceased partners or friends and the witnessing of body 
wasting and deterioration due to AIDS. 
Ambivalence was evident in Question No. 10 over wanting 
to control future events by their actions yet expressing 
hope for a cure or control of the disease and the desire to 
live. Two respondents who answered yes to Question No. 10 
on the pretest had a history of suicidal attempts. In the 
posttest one subject in the experimental group had lost a 
former partner to AIDS in the fourth week of the 
intervention program. All were referred for psychiatric 
follow-up at the end of the post assessments. 
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Results of the outcome data from both scales assessing 
the mood disturbance of depression indicated decreases in 
the level of depression within the experimental group 
between the pre and post scores. Decline was also evident 
in the number of subjects who met the criteria for 
depression in the experimental group compared to the control 
group. However, between the groups the decline was not 
statistically significant. 
Hypothesis 3: The experimental group will show 
increased levels of internal locus of control versus 
physicians' and significant others' control as a result 
of their participation in the biopsychosocial 
educational program "Living with HIV" in comparison to 
the control group. 
The Health Locus of Control (HLOC) Form c (Wallston et 
al., in press) was an 18 item self report instrument 
designed to measure the individuals' beliefs regarding 
control over their health concerns. These concerns include: 
internal locus of control (6), chance (6), powerful others 
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divided between physicians (3) and others (3). The word HIV 
was inserted for the health condition in the assessment 
scale. 
This study was interested in the level of individuals' 
sense of internal control over health issues as compared 
with the effects that physicians and others have on them. 
The subscale of chance was not included in this study. 
Scoring was measured on a 6-point likert format from 
strongly disagree to strongly agree. Total scores in each 
category indicated the level of effect HIV had on the 
subject. 
Table 10 reports a pooled t test comparing differences 
between groups in their mean change from the post score 
minus the pre score. The data indicated both groups 
experienced a decline in their internal locus of control 
mean score. 
The experimental group went from a 23.37 prescore mean 
to a 20.63 postscore mean, while the control group started 
at a lower prescore mean of 19.82 and declined to a 
postscore mean of 18.64. The influence of physicians on the 
experimental group showed only a slight decline in both 
groups. The impact of significant others reversed positions 
between groups. The post scores declined for the 
experimental group and increased in the control group. 
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TABLE 10. BLOC POOLED T TEST MEAN DIFFERENCES BY GROUP 
EXPERIMENTAL 
MEAN STD E T-VALUE P.VALUE 
INTERNAL -2.75 1.48 -0.852 < 0.408 
DOCTOR -0.13 1.94 -0.025 < 0.980 
OTHERS -1. 37 1.33 -1. 211 < 0.256 
CONTROL 
INTERNAL -1.18 1. 08 -0.874 < 0.394 
DOCTOR 0.18 1. 06 0.027 < 0.978 
OTHERS 0.36 0.52 -1.350 < 0.194 
Analysis of the correlated and pooled t-test, along with the 
ANCOVA's were not statistically significant. 
The data suggested a disparity between the experimental 
and the control group's internal mean scores. One sample 
pattern of interest was that of the differences in the 
length of time since the diagnosis. Here time may have 
represented an initial reaction and challenge for control, 
and thus a higher internal score for those recently 
diagnosed. A lower internal score was seen with those 
diagnosed for a longer period of time, perhaps a reaction to 
the failure in scientific efforts. 
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TABLE 11. SUMMARY OF MEANS FOR HLOC BY TIME OF DIAGNOSIS 
INTERNAL DOCTOR OTHERS 
MEAN SD MEAN SD MEAN SD 
LESS THAN YEAR (PRE) 23.54 5.4 15.54 4.1 10.90 2.9 
LESS THAN YEAR (POST) 20.72 6.3 14.45 4.2 10.00 2.8 
GREATER THAN YEAR (PRE) 18.25 5.5 11.62 4.4 9.00 3.3 
GREATER THAN YEAR (POST) 17.75 4.6 12.75 4.0 9.37 3.5 
Table 11 presents the HLOC summary of means data by 
time of diagnosis. Change scores were evident in the post 
test means for internal locus of control at -2.82 for less 
than a year, and 0.50 for greater than a year. Influence of 
a doctor was -1.09 for less than a year, +1.12 for greater 
than a year. And finally, influence of significant others 
was -0.90 for less than a year and 0.37 for greater than a 
year. 
Findings suggested those diagnosed less than a year 
were more vulnerable to decline of internal locus of control 
as compared with those diagnosed greater than one year. 
When looking at sample trends and the possibility of 
influence on outcome data these findings supported this 
vulnerability. In the experimental group seven (88%) were 
diagnosed less than a year, and seven (64%) of the control 
group were diagnosed greater than one year. Further, at the 
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time of the study, eight (100%) of the experimental group 
had a lower CD4 count compared to six (55%) in the control 
group. 
One of the goals in this intervention program was to 
create a partnership in health care decisions between 
physician and patient. The slight decline in belief of 
physician as powerful other suggested some change in the 
balance for health care decisions in the experimental versus 
the control group. The influence of significant others was 
relatively stable between groups. 
Results of outcome data did not support the hypothesis 
of an increase in the experimental groups' internal locus of 
control versus physicians' and others' control compared to 
the control group. In attempts to create a partnership in 
health care decisions a slight decline in physician 
influence did occur within the experimental group, but it 
was not statistically significant. 
Hypothesis 4: Participation in the biopsychosocial 
educational program "Living with HIV" will result in a 
higher level of medical compliance among the 
experimental group versus the control group for a 
period of three months following the completion of the 
program. 
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The Medical Review Log (MRL) was designed for this 
study to log medical compliance for a period of three months 
following the completion of the posttests. Medical charts 
were identified and their progress notes reviewed for 
evidence of clinic attendance. From the physician 
narratives evidence of treatment compliance in medication or 
specialty referrals was also noted. To chart compliance a Y 
(Yes) or N (No) or a NA (Not Appropriate) was entered for 
each subject within the three month time period. 
The data was comprised of the number of appointments 
completed, missed or not scheduled for three months. The 
frequency of medical appointments was based on the 
individual's medical status, and therefore, not everyone was 
scheduled on a monthly basis. Each kept appointment allowed 
for further assessment for compliance of medications and 
specialty referrals. For this small sample size, the 
Fisher's Exact Test of association was utilized to compare 
the groups. 
Table 12 reports the frequency of appointments kept 
during the three month time period. Clinic appointments 
scheduled and completed for the experimental group was 100% 
for all three months. The Fisher Exact Test for Association 
for the experimental group had a p < .01. This compared to 
the control group who had a compliance rate of 56% in the 
first month, 50% in the second and 0% in the third. 
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TABLE 12. FREQUENCY OF APPOINTMENTS KEPT FOR THREE MONTHS 
BY GROUPS 
MONTH 1 MONTH 2 MONTH 3 
YES NO NA YES NO NA YES NO NA 
EXPERIMENTAL 
APPOINTMENTS 8*+ 0 0 3+ 0 5 6+ 0 2 
MEDICATIONS 7 0 1 3 0 0 6 0 0 
REFERRALS 2 0 6 2 0 1 1 0 5 
100% 100% 100% 
CONTROL 
APPOINTMENTS 5 4 2 5 5 1 0 6 5 
MEDICATIONS 1 1 3 3 0 2 0 0 0 
REFERRALS 2 0 3 0 0 5 0 0 0 
56% 50% 0% 
* Fisher's Exact Test 0.0052 p < .01 (one-tail test) 
+ 100% Compliance with Appointments Scheduled 
Medication treatment for the experimental group 
indicated compliance with all agreed upon treatment for 
three months. The control group had compliance with three 
out of four treatment plans. This response represented only 
two months of activity. The inability to assess for the 
third month was due to six failed appointments. 
The experimental group received two specialty referrals 
in both the first and second time period and one in the 
third; all were compliant. Two control subjects received 
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specialty referrals during their first clinic visits and 
showed compliance. No referrals were made in the second and 
none in the third period as appointments were not kept. 
For the total three month period of scheduled clinic 
appointments the data found compliance for the experimental 
group at one hundred percent compared to forty percent for 
the control group. The Fisher's Exact Test was 0.0052 
(one-tail test) significant at p < .01. Assessing 
compliance for medical care and decisions for treatment only 
occurred during the clinic visit; therefore, attendance was 
the major variable in assessing compliance for this study. 
The results of the MRL for the three month period 
following the "Living with HIV" program indicated that the 
experimental group had a significantly higher level of 
compliance in adherence to their medical appointments than 
the control group. 
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QUANTITATIVE SUMMARY OF FINDINGS 
1. There was no significant decrease in anxiety in the 
experimental group compared to the control group as measured 
on the HAS and the IES scales. 
2. There was no significant decrease in mood 
disturbance between the experimental group and the control 
group as measured on the BDI and HAMD scales. There was 
within the experimental group a significant decrease in mood 
disturbance as measured on the HAMD scale. 
3. There was no increase in the internal locus of 
control compared to physician and significant others control 
for the experimental group compared to the control group as 
measured on the HLOC-C scales. 
4. There was a significantly higher level of medical 
compliance in clinic appointments and therefore prescribed 
treatment in the experimental group compared to the control 
group for a period of three months following the completion 




At the completion of the last session of "Living with 
HIV" six study participants in attendance were asked to 
complete a program evaluation (see Appendix C) . The 
evaluation offered questions for each of the six sessions 
and requested comments on the materials and speakers. Three 
responses were offered for each question from: very much, 
enough, and not enough. A final question asked for their 
overall feelings about the program in terms of what was 
helpful and what was missing, to help guide future programs. 
Session I. Introduction to the Program and HIV Clinic 
The first question was assessing appropriate 
preparation in information and scheduled time for attendance 
at the program. Three answered "very much" and three 
"enough". The second question asked if the overview of the 
HIV Clinic as a medical resource was helpful. Five marked 
"very much" and one "enough". General comments praised the 
organization and materials as very informative. One comment 
was "how nice to take part - rather than just listening to". 
Session II. Medical Management of HIV Disease 
Question one asked if the presentation was helpful in 
understanding the disease and treatment options. Five 
marked "very much" and one "not enough". The second 
question was assessing the discussion on healthy life styles 
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and a partnership with the physician. Again, five stated 
"very much" and one "not enough". General comments 
indicated that they would have preferred two sessions on the 
medical issues, not one. However, they found the 
information very helpful. Two felt it was too basic and 
preferred more options. Three commented on how the material 
was presented in a relaxed atmosphere. This last comment 
was important as the medical information covered the HIV 
continuum from serioconversion to the final stage of AIDS. 
Session III. Nutrition 
One overall question for this session asked if the 
presentation was informative enough to assess their eating 
habits and encourage changes. Four marked "very much", one 
"enough", and one "not enough". This was a favorite and fun 
session for all with comments praising the speaker and her 
presentation. Two commented they were amazed at the food 
they needed to avoid. 
Session IV. Legal Issues/Social Security 
This session was divided by subject and speakers. The 
first section of the instrument asked if the presentation on 
the legal issues of being HIV seropositive was helpful in 
understanding their rights. Three responses were "very 
much", one "enough", and two "not enough". The second 
section was designed to give an overview of entitlements 
through social security for future planning. The question 
asked if the material on social security was helpful. Two 
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felt it was "very much", and four "enough". General 
comments said the speakers were very informative. Two 
people expressed gratitude that the legal issues focused 
more on rights than living wills as "people are more fearful 
of losing their rights''. One person found the social 
security information confusing. 
Session v. Resources for Empowerment 
There was only one overall question for assessing the 
presentation on insurance options and managed care as a 
resource for planning health care needs. Three responded 
"very much" and three "enough". General comments were that 
insurance is so individual and difficult to understand. 
Session VI. Handling Feelings/Stress Management 
This session was divided between discussion on the 
emotional response to being HIV affected and coping 
strategies. The first question asked if the session was 
helpful in discussing how mood and emotions impact on coping 
with HIV. Three responded "very much" and three "enough". 
The second question asked if the relaxation techniques and 
self-statements were helpful strategies. Two stated "very 
much", two "enough", and two "not enough". Again, this 
appeared to be a favorite session. Comments suggested that 
it was helpful for one to know if they were OK, or needed 
help. Another stated "we all have our own ways, each is 
interesting and all very individual." 
The final question asked for an overall critique of the 
111 
program and for comments on what they found helpful and what 
was missing and should be included for future programs. The 
following are the six participants' responses, all made 
anonymously: 
How nice to have so much information presented in a 
pleasant and concise manner. I was given more than I 
would have sought - this was great. I feel aware. 
I think for the psychiatrist/depression session you 
should let participants fill out a mini questionnaire 
which could be discussed so that people could decide if 
they needed to get further help. This is a great 
program. Perhaps good for very newly- diagnosed 
patients, but for patients who have been HIV+ for a 
length of time and have educated themselves on some 
issues, some of the information could be more advanced. 
I found the legal and insurance classes quite valuable. 
Thank you. 
I think the program is of valuable help for persons 
dealing with HIV. This program has been well thought 
out. I only wish a little more energy could have been 
put into making the participants share their thoughts. 
I'm very grateful otherwise and hope to be able to get 
more people to come. 
112 
The most important part of this program for myself was 
to really take time and learn what was happening to me. 
I think anyone living with HIV should be able to take 
part in this program. 
I found this program wonderful. I now know were I can 
go if I need more information. I would urge anyone who 
finds themselves dealing with HIV to take this course. 
Back-up materials have been good. I think most people 
would like to have stayed longer rather than 1 1/2 
hours - maybe two hours or three. 
Overall program was excellent on getting to understand 
issues that I wasn't clear on, or just did not know 
about. I believe this type of program is extremely 
helpful for anyone starting an HIV situation, or even 
at certain stages of this illness, just to keep up on 
any new or ongoing issues. I don't feel as lost 
anymore. And the social worker as always was very 
helpful in the process. 
CHAPTER V 
DISCUSSION AND IMPLICATIONS OF THE FINDINGS 
The war on AIDS will be fought by primary care 
providers and won by health educators. 
(AIDS International Conference, 1993) 
INTRODUCTION 
The central purpose of this research was to determine 
the efficacy of the clinical intervention "Living with HIV" 
as a stress inoculation for the emotional distress of being 
HIV positive and to evaluate its clinical importance to the 
field of social work practice and research. To achieve this 
end it is important to first reflect back on the 
quantitative results reported in Chapter IV. Clearly, a 
fuller review and interpretation is needed. Through a 
synthesis of the literature review and findings the clinical 
significance of this study can be considered. 
What do the findings reveal about the intervention 
model of reducing emotional distress in the earlier stages 
of HIV? And how should the psychological responses for this 
sample be interpreted? Importantly, a review of the 
methodology for this study may add to our understanding of 
this research effort and help plan for future studies for 
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this patient population. And finally, how will the clinical 
significance of this study inform social work practice? 
CLINICAL SIGNIFICANCE 
To begin with, the study was successful in producing 
positive responses to the intervention "Living with HIV". 
Foremost was the experimental group's statistically 
significant findings for medical compliance. Determining 
effectiveness of a study can be done through quantitative 
statistics that are significant, without necessarily being 
clinically meaningful (Hollon & Flick, 1988) . The response 
to the fourth hypothesis suggests both determinants were met 
and brings implications for clinical practice in the medical 
setting. 
The first goal of the study's intervention was to 
promote medical education, medical compliance and risk 
reduction behaviors. The program strategy of graded 
exposure to knowledge about the HIV disease with a focus on 
cognitive reframing was meant to engage and motivate 
individuals' responsibility in their own health care. 
Promoting personal control in the health care setting would 
begin to correct earlier negative experiences. Many 
individuals learned their seropositive status over the 
telephone from a clinic or physician's office that they 
engaged for testing. 
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Siegel and Krauss (1991) reported that the need to take 
control of one's health was among the major themes of their 
qualitative study on HIV-infected gay men. Lazarus and 
Folkman (1984) suggested personal control was the 
underpinning for situational appraisal in the stress and 
coping theory. Opportunities to enhance one's appraisal of 
a stressful-life event would lead to a balance in coping 
between planful and emotional focused coping. 
Subjective responses from the program evaluation 
supports both the literature and the outcome data. Of major 
importance was the insight into how the material was being 
perceived. Three participants commented that the medical 
management session was presented in a relaxed atmosphere. 
This session allowed the physician to be informal and to 
create an atmosphere for dual dialogue on health concerns 
and thereby provided a crucial model for future physician 
and patient interactions. Another commented on receiving 
information in a "concise and pleasant manner". And added 
"I feel aware". 
Adding to the sense of personal control were behavioral 
strategies to reduce anxiety that of ten accompany clinic 
visits. In "battle inoculation training" Janis (1983) felt 
positive behavioral changes resulted from an improved sense 
of self-efficacy that could help to reduce the disruptive 
effects of fear. Techniques in reducing stress for clinic 
appointments involved a suggested list of questions and 
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concerns on medications and their side effects as well as 
inquiry on current HIV management. Included were several 
suggested self-talk statements to manage anxiety. The 
significance of the data as measured on the Medical Review 
Log was very supportive of the study effort. Keeping 
individuals motivated and engaged in the health care system 
allows them to take full advantage of advances in treatments 
for HIV. It also creates a framework for hope. 
The second program goal focused on health internal 
versus external control that would enable patients to 
exercise more control over their health by becoming informed 
consumers of health care issues and services while at the 
same time forming decision-making partnerships with their 
health care team. A major concern for HIV-affected 
individuals was the fear of losing access to health care. 
In the era of health care reform, consumer education on the 
myriad of insurance, legal, and entitlement issues was 
addressed in the program. Correlational data supports the 
idea that HIV-affected individuals need to be informed of 
the medical and legal ramifications of their illness for 
access and control of their own destiny (Britton et al., 
1993; Folkman et al., 1993; Siegel & Krauss, 1991). 
Measurement for health locus of control represented the 
third hypothesis in the study. The findings did not support 
the anticipated increase in internal locus of control for 
the experimental group over the control group. In fact, 
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both groups experienced a decline and were more alike than 
different. A change score indicating a decrease in 
physician influence was seen in the experimental group. In 
two other studies (Kelly et al., 1993; Pergami et al., 1993) 
comparison groups did not differ significantly in their 
perceived locus of control. An alternate analysis of the 
data using the time of diagnosis with the level of perceived 
internal locus of control, showed similar findings. Those 
diagnosed less than a year versus those greater than a year 
had almost identical results. This was due to the fact that 
the experimental group had 88% diagnosed less than a year 
compared to the control group with 64% greater than a year. 
The findings for this sample suggested a stronger 
external locus of control versus internal locus of control. 
Another study came to the same conclusion, however, the 
sample consisted of HIV positive and negative women (Pergami 
et al., 1993). It was suggested in Chapter IV that those 
diagnosed HIV less than a year were more vulnerable to 
decline. Another implication is that the diagnosis of HIV 
may stir up self-blame, self-hatred and internal homophobia 
for some gay or bisexual men, thereby decreasing internal 
trust and control (Cohen & Abramowitz, 1990). The majority 
of the sample represented a minority culture whose survival 
had been more dependent on others than self. Combining this 
with the growing uncertainty of the medical care for HIV 
expressed in the community and the media creates additional 
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obstacles. Finally, a possible influence on outcome data 
may be the decision for a double session on the final night 
of the program. 
The third program goal was to provide skill enhancing 
techniques for adaptive coping and reduction of emotional 
distress. The presence of emotional distress of anxiety and 
depression for HIV-affected individuals in the earlier stage 
has been well documented earlier in the literature review. 
It was evident as well in the findings for this study. 
Generalized anxiety for this sample tended to reflect 
psychic or cognitive symptoms more than somatic ones. In 
another study with early HIV the psychic versus the somatic 
yielded significant results, but at the three month 
assessment period (Perry et al., 1991). The experimental 
group had a consistent pattern of higher emotional distress 
scores than the control group. And change scores provided 
evidence of decreases in anxiety and depression within the 
group rather than the expected changes between groups. 
Cohen (1990) felt the ability to cope with the stress 
and anxiety of being HIV-infected begins with a cognitive 
appraisal of the crisis. The study intervention utilizing 
the stress inoculation model contained cognitive reframing 
sessions for control of anxiety along with behavioral 
skills. What was not anticipated was the level of anxiety 
created by attending this program. Ninety minutes prior to 
the first session of "Living with HIV", one female subject 
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called to explain "I can't do it, I'm not ready to deal with 
this yet". She asked to attend the follow-up program and 
offered to complete the posttest. She became a part of the 
control group. 
At the start of the first session one male subject 
related thinking about this program all day and feeling 
almost too anxious to attend. This resulted in a delay of 
the program to allow other participants to verbalize their 
anxiety in coming to the program. A means of handling 
feelings of stress and anxiety by requesting time-out was 
agreed upon. Interestingly, this defense maneuver was never 
used. 
When reviewing the results of the Impact of Event Scale 
a noticeable increased use of avoidance maneuvers was seen 
for the experimental group in comparison to the control 
group. One might suggest that the anxiety generated by the 
program compounded the anxiety of being HIV-affected with 
increasing defensive maneuvers. Perhaps a more viable 
explanation for the differences is found in the time of 
diagnosis and CD4 counts between groups. The experimental 
group had been diagnosed a shorter period of time and had 
lower CD4 counts compared to the control group. Further, 
the possibility of increased coping skills gained from the 
program might have resulted in the lower intrusive thoughts 
through stronger avoidance maneuvers. 
The necessity to combine two topics in the final 
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session raised concerns of influence on the data. 
Discussing the complexity of insurance was anxiety provoking 
on its own, but more so when it was vital to one's 
existence. Evaluation comments confirmed this belief even 
though it provided participants important information. 
However, the next topic on handling feelings and stress 
appeared to be the favorite session. It was also the last 
session and termination issues were raised with the absence 
of two participants. The informality of the program design, 
and the relaxed approach of the psychiatrist encouraged 
interactions among the participants. The difficult area of 
disclosure of diagnosis to family was interweaved with the 
stresses that confront the HIV-affected individual. The 
desire to talk about feelings resulted in less time for 
rehearsing imagery and self-talk behavioral strategies. 
The subjective responses on the last session included a 
sense of loss and desire to continue in some other form. 
Several participants referred to the sessions as "classes" 
and to each other as "classmates''. One participant stated 
"it was helpful to know your (sic) doing OK, or in need of 
help." This comfort in discussing feelings was repeated in 
the observer rated Hamilton Depression Rating Scale at the 
posttest. The outcome data yielded a statistically 
significant decrease in depressive symptoms within the 
experimental group. 
The current dialogue in psychotherapy over the ability 
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to assess "reliable change" or ''clinically significant 
change" was reviewed in the literature (Hollon & Flick, 
1988; Hsu, 1989; Jacobson & Revenstorf, 1988). Reliable 
change began with statistical formulas developed as a post 
hoc measurement for assessing the significance of change 
scores using the absolute value for the instruments. This 
approach posed problems for studies with multiple scales 
making it unclear how to assimilate discrepancies between 
scales (Jacobson, 1988) . For this study the clinical 
significance is assessed less from quantitative findings and 
more from the subjective responses and actions of the 
participants. 
In defining clinical significance or meaningfulness 
Hollon and Flick (1988) felt the ultimate criterion is 
really a matter of values. A reduction in anxiety or 
depressive symptoms is meaningful to the person involved. 
This is especially true for chronically ill population. For 
example, being capable of entering a medical clinic without 
feeling panic, is valuable. Feelings of empowerment when 
advocating for one's legal rights to benefits, entitlements 
and access to care, is valuable. And the enhancement of 
personal control through a partnership in medical 
decision-making promotes dignity. This is valuable. 
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PARTICIPANTS' CLINICAL RESPONSE 
The participants' subjective responses and actions 
ultimately defined the meaningfulness or clinical 
significance of this study intervention. Upon completion of 
the study, four of the eight experimental subjects began 
individual and group counseling through the hospital's 
outpatient mental health service·s. The study appeared to 
have served as a vehicle for linking patients in need of 
additional psychological services. Further responses to the 
psychological instruments found that they served as an 
intervention for change also. The following examples were 
shared at the conclusion of the posttest: 
#002 (control) He stated after the first assessment he 
felt the materials were depressing, yet found it 
mobilizing him into action. First, he decided that he 
was too anxious and tense at work and needed to 
reevaluate his work style. He met with his supervisor 
to help prioritize and pace his work assignments. He 
then followed through on a referral and saw his 
physician regarding his sleep disturbance. He is now 
on medication and reports doing better. Finally, he 
made an appointment to have his eyes examined and found 
little change and decided it was stress and anxiety. 
He stated that being part of the study helped him to 
resume doing things for his health that he had done 
before, but had become complacent about. 
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#021 (experimental) He stated after completing the 
pretest that he was too tense and had to slow down at 
work and not be so compulsive. He, too, changed his 
work pace and style. He felt the scales helped him to 
develop a new attitude about taking care of himself. 
#010 (control) Upon completion of the scales he was 
informed of the next scheduled program. He was very 
relieved, stating he thought he had failed on the first 
scales and would not be included. His scores met 
criteria for clinical depression, anxiety and 
posttraumatic stress disorder. He had been referred 
for counseling and informed the researcher of a pending 
appointment and plan to start group therapy. He was 
grateful for the study. 
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METHODOLOGICAL IMPLICATIONS 
The fact that the present study was based on such a 
small sample suggests caution in the interpretation of the 
results. The anticipated sample size was not achieved as 
the majority of CHC patients, new to the clinic, were in 
more advanced stages than the study required. Even so, the 
study criteria for selecting research subjects was 
maintained, as it supported the literature on the earlier 
stages of the HIV disease. The demographic characteristics 
of the sample provided a profile of HIV-infected individuals 
at the time of recruitment. The inclusion of the CD4 count 
and the time of diagnosis supported both the stage of 
disease and the variability in time of diagnosis when 
seeking medical care. It was anticipated that this added 
dimension might be a contributing factor to the level of 
emotional distress. The reported findings indicate this to 
be the case more for the experimental group than the control 
group. 
This research study followed the principles of the 
classic experimental design, or Design 4 for hypothesis 
testing (Campbell & Stanley, 1963). Its rigorous 
characteristics of pretest-posttest, independent variable, 
control groups, and randomization were intended to equalize 
the comparison groups and any threats to validity. A review 
of some extraneous sources of variability for this study for 
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possible threats to internal and external validity had 
methodological implications for the study intervention and 
its responses. 
INTERNAL VALIDITY ISSUES 
In determining the effects of the independent variable, 
Monette et al. (1986) felt "the central issue in 
experimentation is its utility in enabling us to make 
statements about causal relationships between phenomena" (p. 
226). The experience of being HIV-infected would most 
likely manifest itself equally among the experimental and 
control groups. However, the likelihood for bias of 
maturation occurring is a concern with this "at risk" 
population. In the experimental group one subject 
experienced a major loss with the death of a former partner 
during the fourth session. One would anticipate that this 
significant loss amplified the loss that comes with a 
diagnosis of HIV-positive and had a direct effect on the 
dependent variables from pretest to posttest. This subject, 
who chose to remain in the study, responded yes to the 
question of "intent to kill yourself" at posttest. However, 
at the completion of the study he revealed alcohol problems 
not revealed previously, and accepted and began individual 
counseling shortly thereafter. The quantitative data for 
this subject was affected as was the clinical significance. 
The testing process produced a reaction to the 
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instruments at the pretest that served as an intervention 
for change. This was reported after the posttest by three 
subjects from both study groups. This dramatic reaction, as 
described previously under clinical significance, was a 
surprise to the researcher. On one hand it raised questions 
of undue influence on outcome data, while on the other hand 
it provided answers to a moral dilemma with the study 
design. An ethical concern of this research design was 
providing equal access to the opportunities of the 
experimental intervention. This was controlled by 
duplicating the "Living with HIV" program for the control 
group and their guests after the three month chart review. 
Unexpectedly, the choice of instruments and the individual 
response to them also served as a vehicle for change during 
the testing period. 
Another potential bias was in mortality that resulted 
in the loss of subjects from the comparison groups. In 
large studies attrition occurs and is equally distributed 
between the experimental and control groups. Of concern for 
this study is the possibility that the experimental stimulus 
may have affected the attrition rate. The anxiety of 
attending the program as expressed verbally by one subject 
and behaviorally by another in the experimental group drew 
attention to dealing with this problem in this and future 
studies. Adjustments to the sample were made by moving two 
experimental subjects who completed pre-and-post test to the 
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control group. 
The clinical significance and meaning of this can be 
seen through Hollon and Flick's (1988) model which supported 
the notion that at least three constituencies are interested 
in the outcome of treatment. These three include the 
patient, society, and the professionals involved. The value 
in keeping the two subjects in the study as control was the 
inclusion of their important responses as well as providing 
another opportunity for their exposure to the experimental 
intervention. Secondly, the societal interest came from the 
gain in increased coping and healthy life-styles, and 
conversely, a decrease in the spread of HIV. Third, the 
value for the professional involved was enhanced by the 
patient's continued engagement in the process of change. 
In this study another bias or advantage was in the 
selection of the instruments that were sufficiently balanced 
in content, criterion and construct validity for the 
population being studied. The five scales utilized for 
hypotheses testing (the Beck Depression Scale, the Hamilton 
Depression Rating Scale, the Hamilton Anxiety Rating Scale, 
the Impact of Event Scale and the Multidimensional Health 
Locus of Control Scale) all had properties of validity, 
sensitivity and reliability for this study. Hamilton (1976) 
recognized that patients have many reasons for minimizing 
their symptoms or emphasizing them. This view was the 
impetus for the use of both self-report and clinically rated 
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scales. It also represented this researcher's bias in 
exposing this population to opportunities to openly assess, 
and express, the level of impact their seropositive status 
may have on their functioning. 
The IES and the HLOC had added face validity by 
inserting HIV as the event in question. These scales were 
given after the anxiety and depression scales. This order 
of use might have achieved a different response if the IES 
was given as the first self-report with its attention to the 
impact of HIV, followed by the other scales with the HLOC as 
the end point. 
EXTERNAL VALIDITY ISSUES 
The efficacy of the independent variable for this study 
has been established. Its application to practice, however, 
raises questions about generalization. As Campbell and 
Stanley (1963) succinctly describe the problem: 
Whereas the problems of internal validity are solvable 
within the limits of the logic of probability 
statistics, the problems of external validity are not 
logically solvable in any neat, conclusive way. 
Generalization always turns out to involve 
extrapolation into a realm not represented in one's 
sample (p. 17). 
One major threat to external validity is the possibility 
that experiencing the pretest can alter the subjects' 
response to the independent variable, "Living with HIV." 
The subjective responses at the posttest supports the 
influence of the pretesting on two subjects whose reactions 
lead to self-adjustments in coping with stress. 
129 
From this 
example one could extrapolate influence on the other 
experimental and control subjects. 
Campbell and Stanley (1963) felt the effects of the 
pretest as it restricts external validity will be governed 
by the extent of repeated measures characteristic of the 
population which one wants to generalize. HIV-infected 
individuals are exposed to numerous research studies and 
clinical trials that cover medical intervention, quality of 
life, coping, and prevention. Continuous research serves to 
inform the scientific community in their efforts at primary 
and secondary interventions. Therefore, generalization of 
this study's findings to practice with other stage HIV-
affected individuals is possible. A duplication of the 
pretest effects could mean those individuals unable to 
attend all the sessions had accrued some properties for 
self-adjustment through participation in the pretest alone. 
Another threat to external validity is the concern that 
those studied are indeed "representative" of other 
populations. Monette, Sullivan and Dejong (1986) caution 
that volunteers for studies tend to differ from the general 
population as they are better educated, come from a higher 
social class and are more sociable. The demographics in 
this study sample appear to support that view as they were 
highly educated, with medium to high incomes and volunteered 
to participate. There remains the possibility that the 
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effects of validity demonstrated hold only for the unique 
population that the experimental and control groups were 
jointly selected from. However, the core issue for people 
infected with HIV is in learning how to survive with this 
disease. The study model was structured to allow for 
adaptation of its strategies to fit the focus needs of other 
HIV-affected populations, thus supporting generalization. 
Other methodological implications to the 
generalizability of this study is in the interactions of the 
setting on the effectiveness of the intervention. Again, a 
caution from Campbell and Stanley (1963) on the 
characteristics of the setting that could support the 
experimental intervention in ways not replicated in other 
settings. The program goals were designed to support a 
response to the changing medical management of HIV. 
Therefore, the main focus was on empowerment of individuals 
toward the ability to negotiate and form partnerships with 
their health care team. The ability to create a cognitive 
reframing of their health concerns within the same setting, 
and with some of the same medical staff where the subjects 
receive their primary care provided a unique opportunity. 
Obtaining similar results is more likely to occur in a 
medical setting than in a nonmedical community based 
setting. 
Achieving the desired balance between internal and 
external validity is important to experimental research, but 
not always possible as this study suggests in one single 
study. As Campbell and Stanley (cited in Monette et al., 
1986) suggest "in the last analysis, external validity . 
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is a matter of replication'' (p. 244). The literature review 
provided guidance in the development of this research model. 
Perry et al. (1991) felt "the ability to use our research 
findings to accurately generalize about all subjects will 
only be assured after similar prospective studies are 
conducted elsewhere in other populations" (p. 147). 
Successful replication of the research results across time 
as well as settings will increase confidence in the 
importance of this research design and its findings. 
Finally, the analysis of the findings focused on change 
scores as an assessment of treatment effect. The most 
widely used test is the t test both within the group and 
between the group (Campbell & Stanley, 1963) and proved most 
appropriate for this study. All data except the Medical Log 
Review had preintervention controls with the ANCOVA's 
procedure. This study proved that the reliability of change 
scores is a necessary, but not sufficient condition for 
"clinical significance". 
It is important to keep in mind that this was a small 
sample study (N=l9). Of course, it is always easier to 
obtain a statistically significant result with larger 
samples than with smaller ones. In discussing the lack of 
statistically significant findings in the Concord Study the 
researchers' explanation is worth repeating here. 
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They felt 
"with a disease as devastating as AIDS, a chance of even a 
5% reduction in progression may be attractive to an 
HIV-infected individual" (p. 867). Given the uncertainty of 
an illness which will wax and wane over many years, changes, 
even small ones, are a window of opportunity for increased 
quality of life. 
IMPLICATIONS FOR SOCIAL WORK PRACTICE 
This study has practice implications for clinical 
social workers, and in particular, for those working in 
medical settings. With the new perspective on the medical 
treatment decisions for HIV comes the recognition of a 
change from a biomedical model of AIDS to a biopsychosocial 
model, an approach already inherent in social work practice 
with the "person-in-situation-person-in environment" 
perspective. Social Workers in AIDS care in the beginning 
of this illness described their role more as that of 
"witness" or "mirrors" to HIV-infected individual's struggle 
and personal evolution (Ryan, 1989) . This 
countertransf erence to the overwhelming feelings of 
hopelessness and helplessness needs a cognitive reframing. 
The task of working with HIV-affected people is 
overwhelming, but not unfamiliar to the social work field of 
practice. The study stress-inoculation model, a model of 
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preparation is truly bidirectional in its application. A 
goal of this study was to proactively assist patients in the 
pre-AIDS stage of their disease with cognitive-behavioral 
skills for coping and survival for the present and future. 
The complexity and dynamics of this disease challenges 
social workers schooled in the biopsychosocial model as 
agents and advocates of change. The social worker Code of 
Ethics mandates that social workers be leaders in seeking 
solutions to the complex problems that HIV infection and 
disease present to individuals and society. 
The process of empowering the experimental group as 
consumers of health care services was positively correlated 
with their medical compliance. The intervention "Living 
with HIV" served as a transactional model between the 
patient, their health care team, and the community. The 
professionals participating in the program reported feelings 
of "helpfulness'' in providing strategies for participants to 
cope and live with HIV. These shared feelings define the 
stress inoculation model of preparation as bidirectional in 
its application between those living with HIV, and those 
providing their care. 
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RECOMMENDATIONS 
This model of intervention was developed from clinical 
practice with a predominately homosexual population. The 
face of AIDS is changing and bringing more complexity with 
the growing number of infected women and children, as well 
as dual and triple diagnosed individuals. Group 
interventions will need to be structured to meet the 
particular stressful needs of those targeted populations 
(Janis, 1983). This study provides some guidance for future 
efforts along with some recommended changes. 
First, the study responses were significantly different 
for those diagnosed less than a year and those for a longer 
period of time. The criteria for this study attempted to 
combine those subjects in the earlier stages of HIV as 
defined by the clinical stages, with the new guidelines for 
medical management in the earlier stages of the disease, to 
patients new to the clinic within the past six months. 
Understanding that people enter the medical system at 
different points along the HIV continuum, this created a 
dichotomy in time since diagnosis and time in adjustment. 
It is suggested for future studies that more careful 
attention be given to the selection of subjects in terms of 
length of diagnosis, and the stage of their disease. 
Second, the use of anti-depressant medications should 
be considered as it would affect data results. Inclusion or 
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exclusion of these subjects must be based on the goals and 
intent of the study. Third, the order of the use of scales 
might produce a different response if the scale measuring 
the impact of the HIV illness begins the assessments. This 
researcher encourages the replication of the research design 
that includes pretesting. Results have shown that they too 
serve as interventions for change, motivating cognitive 
ref raming to those unable to unwilling to be exposed to the 
intervention. 
Fourth, the order of the program might produce a 
different result. The issue of termination needs attention, 
but having the last session focus on handling feelings may 
or may not have influenced the absence of two participants. 
Fifth, the program needs to be extended through 
identification of additional adaptive characteristics. 
Sixth, finally the need for participants to talk about their 
feelings requires more than a half-session of time; a full 
session on this topic is recommended, along with a follow-up 
session for behavioral interventions giving more time and 
attention to self-talk, imagery and relaxation techniques. 
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CONCLUSION 
The findings from this study are encouraging. The 
psychoeducational program, ''Living with HIV" proved to be 
effective in producing awareness and change within the 
experimental versus the control group for this sample 
population. The national trend for infection rates for HIV 
continues to grow, and with it, increased complications that 
challenge social workers to provide new and more creative 
modalities for effective coping. The medical setting is the 
core to the linkage of care for HIV-infected individuals, 
and the medical social worker is their advocate in the 
systems of care. Intrinsic in all empirical research 
efforts with this population is the need for patient 
empowerment for coping and survival while living with HIV. 
It proves vital in the medical setting where the 
uncertainty, unpredictability, and complexity of this 






"LIVING WITH HIV" 
THIS RESEARCH STUDY WILL EXAMINE THE EFFECTIVENESS OF A 
COMPREHENSIVE EDUCATIONAL PROGRAM IN REDUCING THE EMOTIONAL 
DISTRESS OF BEING HIV-INFECTED IN THE PRE-AIDS STAGE OF THE 
DISEASE. 
THIS 6 WEEK PROGRAM WILL MEET ONCE A WEEK FOR 90 MINUTES PER 
SESSION AND BE FACILITATED BY THE CLINIC SOCIAL WORKERS AND 
INCLUDE AN INFECTIOUS DISEASE PHYSICIAN, A PSYCHIATRIST, 
CLINICAL NURSE SPECIALIST, DIETITICAN, LAWYER AND A SOCIAL 
SECURITY ADVISOR. THE PROGRAM INTERVENTIONS DESIGNED FROM THE 
LITERATURE REVIEW ON THE IMPACT OF HIV IN THE EARLIER STAGE OF 
DISEASE ARE INTENDED TO: 
1) PROMOTE MEDICAL EDUCATION, MEDICAL COMPLIANCE, AND RISK 
REDUCTION BEHAVIORS. 
2) ENABLE PATIENTS TO EXERCISE MORE CONTROL OVER THEIR HEALTH 
BY BECOMING INFORMED CONSUMERS OF HEALTH CARE SERVICES, AND 
FORMING PARTNERSHIPS WITH THEIR HEALTH CARE TEAM. 
3) PROVIDE SKILL ENHANCING TECHNIQUES FOR ADAPTIVE COPING AND 
REDUCTION OF EMOTIONAL DISTRESS. 
THERE IS NO CHARGE TO ATTEND THIS PROGRAM. 
CRITERIA: PATIENTS WHO ARE NEW TO THE COMPREHENSIVE AIDS CENTER 
WITHIN THE PAST SIX MONTHS WITH A CD4 COUNT OF GREATER THAN 200 
WITH NO RECORD OF OPPORTUNISTIC INFECTIONS THAT DEFINE 
PROGRESSION TO AIDS CONFIRMED BY THEIR MEDICAL RECORDS. 
PATIENTS WITH A HISTORY OF DRUG ABUSE MUST BE IN RECOVERY FOR 
AT LEAST THREE YEARS. 
SCHEDULE: THE STUDY IS SCHEDULED TO BEGIN ON THURSDAY, JANUARY 
13th FROM 6:00 -7:30 PM. THIS RANDOMIZED STUDY MEANS HALF OF 
THE PARTICIPANTS WILL BE INVITED TO ATTEND THIS PROGRAM AND THE 
OTHERS WILL BE ASKED TO ATTEND OUR NEXT SCHEDULED PROGRAM IN 
APRIL. AN HOUR INTERVIEW BEFORE AND AFTER THIS PROGRAM IS 
REQUESTED. THEREFORE, PLEASE CONTACT ME UPON RECEIPT OF THIS 
LETTER TO SCHEDULE AN APPOINTMENT AT YOUR CONVENIENCE. PLEASE 
CALL NANCY CADDICK AT (312) 908-5116 BETWEEN 9:00 AM AND 5:00 
PM, OR PAGE ME THROUGH (312) 908-2060. THANK YOU FOR YOUR 
CONSIDERATION. 
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APPENDIX B 
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EFFECTIVENESS OF A COMPREHENSIVE EDUCATIONAL PROGRAM IN 
REDUCING EMOTIONAL DISTRESS FOR HIV-INFECTED PEOPLE IN THE 
PRE-AIDS STAGE OF DISEASE. 
INFORMED CONSENT 
INTRODUCTION 
This research study will examine the effectiveness of this 
educational program in reducing the emotional distress of being 
HIV-infected for patients new to the Comprehensive AIDS Center 
within the last six months, and whose CD4 count is greater than 
200 with no record of opportunistic infections that define 
AIDS. 
Research has shown that patients in the earlier stages of the 
HIV disease experience significantly higher levels of 
depression, mood disturbance and anxiety than do those patients 
with AIDS. Thus, the need exists for a comprehensive approach 
towards adaptive coping by providing consumer education on 
medical care, mental health care, nutrition, and legal and 
insurance advice. 
PURPOSE 
The purpose of this study is to examine the effectiveness of 
the program "Living with HIV" as an intervention to reduce 
depression and anxiety while at the same time increasing a 
sense of control and preparation through consumer education and 
stress reducing techniques. The program interventions designed 
from the literature review on the impact of HIV in the earlier 
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stage of the disease are intended to: 
1) promote medical education, medical compliance, and risk 
reduction behaviors. 
2) enable patients to exercise more control over their 
health by becoming informed consumers of health care 
services, and forming partnerships with their Health Care 
Team. 
3) provide skill enhancing techniques for adaptive coping 
and reduction of emotional distress. 
PROCEDURES 
Should I be eligible to participate in this study, and I agree, 
I will be interviewed and asked demographic information such as 
age, sex, ethnicity, marital/partner status, education, 
employment status, HIV risk factor and CD4 count. I will also 
be asked to complete 5 psychological assessment scales that 
will take approximately 55 minutes. Next I will be randomized 
(assigned by chance) to either: 
1. attend a six week, 90 minute per week session of the 
"Living with HIV" program, and I may bring two guests. 
Information about the program schedule and location will be 
made available to me. 
2. offered current clinic services and be invited to attend 
the next program anticipated early in 1994. 
Upon completion of the six week program, I will be asked to 
once again complete 5 psychological assessment scales that will 
take approximately 55 minutes. 
BENEFITS 
The benefits to me for my participation in this study are to 
receive from my Health Care Team a comprehensive educational 
program to aid me and my significant others in understanding 
and living with the HIV disease. 
By participating in this study I will be assisting in 
determining the importance of this model as a continuing 
intervention for patients in the pre-AIDS stage of the disease 
at the Comprehensive AIDS Center. 
RISKS 
The only slight concern involves the possibility of an 
emotional reaction to the psychological assessment scales or 
with the materials presented at the program. Should this occur 
in any slight way, I am encouraged to contact one of the clinic 
social workers. If these feelings persist, I am free to 
withdraw from the study at any time, and that this would not 
affect my relationship with the clinic or any member of the 
medical staff. 
ALTERNATIVE PROCEDURES 
New Comprehensive AIDS Center patients receive a clinic packet 
describing the various services and staff members. Should I 
desire additional information or resources I can request an 
appointment with one of the clinic social workers. 
COSTS 
There are no related costs to participating in this study. 
CONFIDENTIALITY 
My research records will be kept confidential and in a locked 
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file. I will be identified by a number code on the demographic 
and psychological assessment scales listed on a master list to 
be destroyed at the completion of the study. Only first names 
will be used during the program. None of the study information 
will be included in my medical records. I will not be 
personally identified in any publication about this study. 
SUBJECTS RIGHTS 
Participation in this study is voluntary and refusal to 
participate will involve no penalty or loss of benefits. As 
stated above, subjects may withdraw at any time without penalty 
or loss of benefits, and that withdrawal will not affect their 
relationships with the clinic or any member of the medical 
staff. Any additional questions or concerns regarding this 
study should be directed to Nancy Caddick at (312) 908-5116 
between the hours of 9:00am to S:OOpm, Monday through Friday. 
CONSENT 
I agree to participate in the research study outlined above and 
I will receive a copy of the consent form. 
Signature of Subject Date 






January 6, 1994 
Dear Study Participants; 
The "Living with HIV" research study is scheduled to 
begin next Thursday, January 13th, and for the next five 
consecutive Thursdays ending on February 17th. The program 
will run from 6:30 to 8:00 pm and will meet in the Conference 
Room on the eighth floor of the Passavant Pavilion at 303 E. 
Superior Street. The agenda for the program is enclosed and 
is designed to address the medical, psychosocial and 
psychological issues of being HIV-infected. Several 
psychoeducational strategies have been created to help you 
cope and live daily with HIV, therefore, we hope you will 
arrange your calendar to allow attendance at each session. 
We would like to know in advance if you will be bringing 
guests ( up to two) and if you will be driving in order to 
arrange for parking at the NMH parking lot on Erie and 
Mcclurg Streets (across from CBS). Also, we plan to have 
light refreshments, and for confidentiality, we will use only 
first names during the program. 
Please leave a message for me at (312) 908-5116 regarding 
your ability to attend as well as parking needs and if you 
will bring guests. Looking forward to seeing you on Thursday, 
January 13th. 
Nancy Caddick 
Clinical Social Worker 
STRATEGIES FOR LIVING DAILY WITH HIV 
l. AWARENESS OF THE HIV CLINIC'S OPERATION AND STRUCTURE 
CREATES ACCESS TO SERVICES AND INFORMATION TO ASSIST 
IN YOUR HEALTH CARE NEEDS. 
2. DEVELOPING A PARTNERSHIP IN HEALTH CARE TREATMENT 
DECISIONS WITH YOUR PHYSICIAN AND HEALTH CARE TEAM. 
3. PREPARE FOR YOUR CLINIC APPOINTMENTS WITH QUESTIONS 
ANO/OR CONCERNS. BRING A LIST OF YOUR MEDICATIONS. 
4. ATTENTION TO YOUR NUTRITIONAL HABITS IN FOOD CHOICE, 
PREPARATION AND SUPPLEMENTS. 
5. UNDERSTANDING YOUR RIGHTS TO LEGAL PROTECTION UNDER 
THE LAW, AND ELIGIBILITY TO FEDERAL AND STATE 
ENTITLEMENTS AND PROGRAMS AS NEEDED. 
6. BECOME A CONSUMER OF HEALTH CARE SERVICES -KNOW YOUR 
POLICY AND ITS BENEFITS - KNOW WHO DOES WHAT, WHEN 
ANO HOW. 
7. PAY ATTENTION TO YOUR MENTAL HEALTH NEEDS ANO SEEK 
HELP THROUGH INDIVIDUAL OR GROUP THERAPEUTIC SUPPORT. 
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LIVING WITH HIV 
PROGRAM EVALUATION 
We would appreciate your comments on this program to help us 
prepare for future ones. Please Place an X through the word 
that best describes your feelings. 
SESSION I. Introduction to the Program and HIV Clinic: 
1. Did you feel you received enough information to organize 
your time and prepare you for this program? 
VERY MUCH ENOUGH NOT ENOUGH 
2. Did you feel the information on the HIV Clinic provided 
you with a working understanding of how it operates that will 
be helpful to you? 
VERY MUCH ENOUGH NOT ENOUGH 
COMMENTS ON MATERIAL AND SPEAKERS=~~~~~~~~~~~~~ 
SESSION II. Medical Management of HIV Disease: 
1. Did you find this presentation helpful in understanding 
the HIV disease and treatment options? 
VERY MUCH ENOUGH NOT ENOUGH 
2. Were the suggestions for strategies for a healthy life 
style along with ways to work with your physician helpful? 
VERY MUCH ENOUGH NOT ENOUGH 
COMMMENTS ON MATERIAL AND SPEAKER~~~~~~~~~~~ 
SESSION III. Nutrition 
1. Did you find the presentation on nutrition provided the 
information you needed to assess your eating habits and make 
appropriate changes? 
VERY MUCH ENOUGH NOT ENOUGH 
COMMENTS ON MATERIAL AND SPEAKER~~~~~~~~~~~~ 
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SESSION IV. Lesal Issues/Social Security 
1. Did you find the presentation on the legal issues on 
being HIV-infected helpful in understanding your rights? 
VERY MUCH ENOUGH NOT ENOUGH 
2. Was the information on Social Security helpful for you at 
this time? 
VERY MUCH ENOUGH NOT ENOUGH 
COMMENTS ON MATERIAL AND SPEAKERS~~~~~~~~~~~~ 
SESSION V. Resources for Empowerment 
1.Did you find this presentation on insurance issues helpful 
in understanding your choices in health care, as well as ways 
to plan for your health care needs? 
VERY MUCH ENOUGH NOT ENOUGH 
COMMENTS ON MATERIAL AND SPEAKER~~~~~~~~~~~~~-
SESSION VI. Handling Feelings/Stress Management 
1. Did you find this session helpful in discussing the ways 
that mood and emotions impact on coping with HIV? 
VERY MUCH ENOUGH NOT ENOUGH 
2. Do you feel that using the relaxation techniques and 
self-statements will be helpful for you to cope with your 
feelings? 
VERY MUCH ENOUGH NOT ENOUGH 
COMMENTS ON THE MATERIAL AND SPEAKER~~~~~~~~~~~ 
WHAT IS YOUR OVERALL FEELINGS ABOUT THIS PROGRAM? WHAT DID YOU 
FIND HELPFUL, WHAT WASN'T? YOUR COMMENTS ARE GREATLY 







CODE NO: START 
DATE: 
.s..EX,: M. ___ F __ 
AQE: __ _ 
ETHNICITY: White African-American Hispanic Asian 
Other ______________ _ 
MARITAL/PARTNER: Single Married/Live-in-Partner 
Separated Divorced Widowed 
EDUCATION: <HS HS <C C G Highest Level __ __ 
EMPLOYMENT: Full-Time Part-Time Unemployed 
RISK FACTOR: Gay IVDU Transfusion Hemophiliac Partner 
ga: __ _ 
DATE OF DX:MONTH/YEAR 
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UNIVERSITY of PE.YNSYLVA.VIA 
PHIL\DELPHI.\ 19UJ-!-:32-!6 
October 1, 1993 Please reply to: Center for Cugnitir:e Theraplj 
Nancy Caddick 
Room 73.+. The Sc1em:e CL·lltl'r 
'](;(Ml \larket Strl'c•t 
680 N. Lake Shore Dr. 
Chicago, Il 60611 
Dear ~s. Caddick 
Phil .... P. \ l9 l0.J-2fi.J.'i 
215-.'>98-.J l 00 
F:c" 2!5-·'>9.'i-l~fi5 
On behalf of Aaron T. Beck, M.D., I am responding to your 
recent inquiry regarding our research scales. 
You have Dr. Beck's permission to use and reproduce the 
scale(s) checked below only for the designated research project 
that you described in your letter. There is no charge for this 
permission. 
However, in exchange for this permission, please provide Dr. 
Beck with a complimentary copy of any reports, preprints, or 
publications you prepare in which our materials are used. These 
will be catalogued in our central library to serve as a resource 
for} other researchers and clinicians. 
_../_ B eck Depression Inventory (BO!) Weekl 
eek Anxiety Inventory (BAI) 
_ Hopelessness Scale (HS) 
Suicide Intent Scale (PRTS) 
_Anxiety Checklist (ACL) 
(CCL) _ Beck Self-Concept (BSCT) 
fs't. 'S'S' Pnfunctional Attitude Scale (DAS) 
If you have any further questions, feel free to contact me. 
Sincerely, 
t' d. ,;__,;_,,,, 
Karen A. Quinn 
Assistant to Aaron T. Beck, M.D. 
NOTE: Permission for inclusion of the BDI, BAI, BS, SSI, and 
BSCT in any publication must be obtained from The 
Psychological Corporation; telephone t: 1-800-228-0752. 
H::lITLi!con Depression Racing Sc1le (H_-\_\ [Q) 
Q1 How depressed are you? 
Sc:c~ a;; "c: at all 
~ St.:::-e ~ if 1 :i~!!e = Sc::--? : 1f ·~::ca!"a:e!y s.: = s~:re 3 d 3 ~c: 
_ S..:::-:: ~ 1: ~:<::?r:ie~y s.: 
Q2 De '(Ct:. fee! guii:-1 about things ti": at you 
have cone er thct.:ght? 
~ S..:: ... ~ ·J ;f ."":c: at ail = 5.::r? ~ :r: :i~!a 
_ S·::.:""e: .f ""'.'";-:.=.era~:'.·i s.: 
.03 Is i-r taki:-:~ [cnge; to ~et aff to s!eep? 
- S..:::"! : " . ·-
- Sc::-! : if s,::-:"":eti:-:-:!s 
Q4 Do you sleep fi-:7:.:ily - of:en 
a't.raker.ir.g., 
= Sc:::-? ·J If ..... c 
Sc::-= i if sc.-:":a~!;.:.es 
Q5 Do you waken earlier than usual 
anc then find yourself unable to get 
back to sleep? 
Sc::r= IJ if r::: 
Sc::r: i if sc~ati~es 
Sc::r= 2 if ai•.vays 
Q6 Have you lest imerest in your work 
or hobbies? 
Sc::r? a if r.ct at all 
Sc:ra 1 if 3 lit:le 
Sc::re 2 if ~cceraceiy so 
Sc:ra 3 if a loc 
Sc::re ! if ext:!mefy so 
07 ls life pointless? 
= Sc:r! a if 110 = Sc::ra 1 if yes 
QS Have you thought of ending it all? 
·= Seer! a if r.c ·= Scor~ t ii yes 
Q9 Have you made plans to kill yourself? 
Scor? u ,; :ic 
- S1::r!? T d ·;~S 
Q10 Have you a:::mpted to -or do you 
int:r.d to - kill yoursa!f? 
= Sc:r~ ·J 1.: ."'..: = S.::r: : .: _1~s 
Q~ i De you:::' ::iat you are sfc,:1er than 
ycur liCi~.:l or usual sp::C? 
= S;::.·a J 
::: Si:::-:~·.·.: .:::! = St.::;~: .: -:::~;:;!y so 
S.:::-:: : .: :: 
Q'12 Do ycu fe~1 a~xicl!s cr~a::se? 
S:.::.~a . . : .: ::::~ 
Sc:c: : : ; :: 
Qi3 Do you s;.;:'"'e; from ar:y ;::hys;caf 
s·1mt:=:ci7.s? 
014 Are ye!.! -.·:: i:-fed tha! you mi;ht have a 
ser:ous ii!.-: ass such as cancer or VD? 
Q15 Have you lest interest in sex? 
Sc::r'? •J :f :-:c = Sc::ra 'i if sc~~timas = Sc::ra Z :f a!ways 
Q 16 Have ycr...:. lost weight recently - exc!ud-
ing that cr...:.e to dieting? 
Sc~re 0 :: ."':c: ac all 
Seer! 1 if a !it::e 
Sc~r:e : if ."':":CC!rata!y so 
_ Sc::ra J :f ! ~ot 
Scor! .! if !xt:-!me!y so 
Q17 Are you a"'C your worst early in the day-
but improve as the day goes on? 
St.::Jr~ ,J 1f .~~ 
- s..:~r! i ;: s.::":"":e~irnes 
Sc::r! ~ :: ~l..-1a·1s 
HA;';;Q S~:c~ \lter.1s 1-171 _______ _ 
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Hamilton Anxiety Rating Scale 
lnsrr:zc::ons: Th:s chc:ckli'.\! is :o ~H;s~ :.ic physician or psyc!'u::tnst :n i..:vaiu::ung e:::::i ;:it:..:::c J:i :v ~:.; .;.:;::~ ~f Jn.t:e::· ana ;:::t.::~aog1c:1 
c:or.a::ion. Ph:::sc :il! ::: !he appropn:w: ~ttng: 









\Vorr::s. J.r.~~.::o:uon of 
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F::~~ings cf :.:::sior:. 
fat:g::::::::. :HJ~!'! re· 
si:cr:s::. :-:-:.:·:::d to ::::.rs 
e~sdy. :::~~ling. fe:!-
ing:s ci ::s::!ssn::ss. in-




ing sle:;: 1:::: :·:mg•.;e on 
w~~i::g . .::!!~S. :light-
rn~res. :i.1~:-::-~:::-crs 
Dif::=·~lti' ~:-. ::~c:nt:ation. 
poor :r.e~::::: 
Loss of i:it::m. lac:, of 
pte:isur: i:: ~obb1cs. de-
pression. e~ly waking, 
di umai s·.~;:::~ 
P1ir:s and lc~:s. twitching. 
stiffness. m·.-oc!onic 
jerks. griocfq of teeth, 
unste:iav vo:c:. in-
c:c:ascd · :r:us.::.:.iu tone 
Raring 















T:nnl(:.:s. :::.::-:-::":i ci -.·u1on. 
hot lo.! :::: :~us.':::s. feei· 
ir?gs cf ~~::.:.,i:=:ss .. picking 
sensJ.r:c:: 
T.::::!-.yc:;::J.. :!:::::rions. 
p::.1~ \~. ::-.::.~:. ·.;:,~bci:-.g or· 
·.~ssc:::i. :·:.:::::::; :·:~Er.gs. 
?:-!ss;,,.::-~ ::- .:::-.::::-.:::o:i '.n 
::-:!s: . ..::-:.: .. ::; :·!!:i~gs. 
s:g.""::::; . .::. :::::.:. 
J'.:-::c:..:::·. - : .:. ::::o·,.;,.·ir.g. 
·..i-tr.c. ;,:.:.:~.::::.~ pa1:-.. 
·,:.:.-:-:::-:; ::::-:::.::::-:s. Jbdo-
:7::~:.: ~··.:.~:':!i3. 1l'...!S~:.. 
·1orr:::::-:~. :..::-:::-:~:::.t. 
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50. 
IMPACT OF EVENT SCALE 
( IES) 
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Being HIV-infected is a stressful life event. Below are some 
statements made by people about this stressful live event. Please 
read each item and decide how frequently each item was true for you 
during the last seven (7) days in regards to being HIV-infected. If 
the item did not occur in the past seven days, choose the "Not at 
all" option. Circle the number that best describes each item. Please 
















I thought about it when I 
didn't mean to. 
Not at all 
1 
I avoided letting myself get 
upset when I thought about it 
or was reminded of it. 
I tried to remove it from memory. 
I had trouble falling asleep or 
staying asleep, because of pictures 
or thoughts about it that came into 
my mind. 
I had waves of strong feelings 
about it. 
I had dreams about it. 
I stayed away from reminders of it. 
I felt as if it hadn't happened or 
wasn't real. 
I tried not to talk about it. 
Pictures about it popped into 
my mind. 
Other things kept making me think 
about it. 
I was aware that I still had a lot 
of feelings about it, but I didn't 
deal with them. 
I tried not to think about it. 
Any reminder brought back feelings 
about it. 





































































INSTRUCTIONS: Each item below is a belief statement about HIV with which 
you may agree or disagree. Beside each statement is a scale which ranges 
from strongly disagree (1) to strongly agree (6). For each item we would 
like you to circle the mumber that represents the extent to which you 
disagree or agree with the statement. The more strongly you agree with a 
statement, then the higher will be the number you circle. The more 
strongly you disagree with a statement, then the lower will be the 
number you circle. Please make sure that you answer every item and that 
you circle only one number per item. This is a measure of your personal 




1. If my HIV worsens, it is my own behavior 
which determines how soon I feel better 
again. 
2. If I see my doctor regularly, I am less 
likely to have problems with my HIV. 
3. Most things that affect my HIV happen to 
me by chance. 
4. Whenever my HIV worsens, I should consult 
a medically trained professional. 
5. I am directly responsible for my HIV getting 
better or worse. 
6. Other people play a big role in whether my 
HIV improves, stays the same, or gets worse. 
7. Whatever goes wrong with my HIV is my own 
fault. 





SD MD D A MA SA 
1 2 3 4 5 6 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 















9. Whatever improvement occurs with my HIV 
is largely a matter of good fortune. 
10. The main thing which affects my HIV is what 
I myself do. 
11. If my HIV worsens, it's a matter of fate. 
12. Following doctor's orders to the letter is 
the best way to keep my HIV from getting 
any worse. 
13. If my HIV takes a turn for the worse, it is 
because I have not been taking proper care 
of myself. 
14. The type of help I receive from other people 
determines how soon my HIV improves. 
15. In order for my HIV to improve, it is up to 
other people to see that the right things 
happen. 
16. I deserve the credit when my HIV improves 
and the blame when it gets worse. 
17. If I am lucky, my HIV will get better. 
18. As to my HIV, what will be will be. 
SD MD D A MA SA 
1 2 3 4 5 6 
1 2 3 4 5 6 
1 2 3 4 5 6 
1 2 3 4 5 6 
1 2 3 4 5 6 
1 2 3 4 5 6 
1 2 3 4 5 6 
1 2 3 4 5 6 
1 2 3 4 5 6 
1 2 3 4 5 6 
MEDICAL REVIEW LOG 
Date Reviewed~~~~~~~-







Guidelines: Kept appointments, took all medications agreed upon 
and followed through on speciality referrals 
Key: Y (YES), N (NO), NA (Not Appropriate) 
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Office for the Pror=ion cf Research Subject! 
!mlitmiaul Rmew Boon! 
Animal ~ .t: Use Commiuee 
Ncverr:!:::e:::- 1, 1993 




Re: Effectiveness of a Biopsychosocial Educational Program. 
in Reducing E:motional Distress Using the Stress Inoculation 
Model for HIV-Infected People in the Pre-AIDS Stage of 
Disease 
Dea:::- Ms. Caddick: 
At its October 29, 1993 meeting, the Insti~uticnal Review Board 
conside:::-ed and approved* your submission referenced above for a 
one-yea:::- period ending October 31, 1994. This approval applies 
to the use of human subjects only, and dces not cons~itute 
scientific approval of the project. Scientific approval must be 
obtained from the NMH or RIC Research Committee befc:::-e the 
project may be initiated. 
IRB approval is given with the understanding that nc changes may 
be made in the procedures to be followed nor the consen~ form(s) 
to be used until such modifications have been submitted to the 
IRB fa:::- review and have been given approval. 
Any unanticipated problems involving risk to human subjects and 
any serious adverse effects must be reported promptly to the IRB. 
One month prior to the expiration of this approval, you will 
receive notification of the need for updated information to be 
used for the project's periodic review. Information concerning 
implementation and results to date will be required at that time. 
c~:;/f /iZiw~ 
~:ne G. IRichmond 
Manager 
*Please delete the first sentence in the Risk section. Copy the 
IRB when this is done. 
cc: John Phair, M.D. 
Robert Murphy, M.D. 
Baiba Berzins 
Tamara Norman 
313 !aat Chlcaao Au••• Chlcaao, llllnol1 "'11-Jttl 311°513°'331 I P'AX 312-513-1555 
Ornce ot the Vice Pruldeat tor Ruearda a•d Graduate Studies 
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RESEARCH COMMIITEE 
Norr/Jwr:stenz Nemon3.I Hospiu.I 
Office of Researdl 
215 E. ChiC1go Ave. #913 
(312) 908 - ::670 OFFICE 
(312) 908 - 0051 FAX 
December 8, 1993 
Nancy Caddick, LCSW 
Comprehensive AIDS Center 
Passavant, Room 826 
Chicago Campus 
RB: Research study #93-11-14 
Vett:raDS ALQUs 
Lakeside :'vfed.ic:U C:nter 
RESEARCH OFFICE 
.lOQ E. 0 ntario. Rm. 10 l 
(312) 943~. fat. 511 
Effectiveness of a Biopsychosocial Educational Progr~m in 
Reducing Emotional Distress Using the Stress Inoculation 
Model for HIV-Infected People in the Pre-AIDS Stage of 
Disease 
Dear Ms. Caddick: 
The above referenced project received scientific and 
administrative APPROV1J. from the NMH Research Committee and 
Office of Research on Nove1Dber 17. 1993. The committee ~ishes 
you success in your endeavor to accomplish this project. 
You may commence with this project provided that APPRDV1.L 
has been received from the Institutional Review Board for the 
use of human subjects, and administrative issues are resolved 
(i.e. executed contract containing an indemnification clause, 
account established for ancillaries services, etc). 
If you need any additional assistance regarding this 
project, please do not hesitate to contact us. Thank you. 
Sincerely, 
•tJ 1 /,..- I 
f ~-1~/c::.-. 
<i .. -
Pe~r J. Kahrilas, M.D. 
Chairman 
NMH Research Commit~ee 
~JJ.*'-•-41 
Bonnie Aguda 
Director of Research 
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INSTITUTIONAL REVIEW BOARD 
RESEARCH SERVICES OFFICE 
LOYOLA UNIVERSITY OF CHICAGO 
6525 NORTH SHERIDAN ROAD 
CHICAGO IL 60626 
Tel: {312) 508-2471 Matthew Creighton, SJ, Chair 
Investicator: 
Home Address: 
October 13, 1993 
Nancy S. Caddick 
680 North Lake Shore Drive 
#1311L 
Chicago, Illinois 60611 
Home Teleohone: 951-7348 [Area Code: 312] 
I Please check the above information fer accuracy i 
I and call in any corrections to 508-2471 ; 
Dear Colleague, 
Thank you for submitting the following research 
project for review by the Institutional ?.eview Board fer 
the Protection of Human Subjects: 
Project Title: Effectiveness of a Bio9sychological 
Education Program in Reducing Emotional 
Distress Using the Stress Inoculation 
After careful examination of the materials you submitted, 
we have approved this project as described for a period of 
one year from the date of this letter. 
Approximately eleven months from today, you will 
receive from the I?.B a letter which will ask whether you 
wish to apply for renewal of IRB approval of your project. 
You will be asked whether there have been any changes in 
the nature of the involvement of human subjects in your 
project since it was first approved, and whether you 
foresee any such changes in the near future. If your 
responses to these questions are timely and sufficiently 
explicit, the IRB will at that time renew your approval 
for a further twelve-month period. If you do not return 
that form by October 13, 1994, however, your approval will 
automatically lapse. 
This review procedure, administered by the IRB itself, 
in no way absolves you personally from your obligation to 
inform the IRB in writing immediately if you.propose to 
make any changes in aspects of your work that involve the 
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participation of human subjects. The sole exception to 
this requirement is in the case of a decision not to 
pursue the project--that is, not to use the research 
instruments, procedu=es or populations originally 
approved. Researchers are respectfully reminded that the 
University's willingness to support or to defer.d its 
employees in legal cases that may arise from their use of 
human subjects is dependent upon those employees' 
conformity with University policies regarding IRB approval 
for their work. 
Should you have any questions rega=ding this letter or 
the procedures of the IRB in general, I invite you to 
contact me at the address or the telephone numbe= shown en 
the letterhead. If your question has directly to do with 
the project we have just approved for you, please guote 
file number 1080. 
With best wishes fer your work, 
Tn~.u» ~~(j-J 
Matthew Creighton, SJ 
cc: Graduate School/WTC 
inter-office memrar.cum S. Condon 
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ANALYSIS OF COVARIANCE TABLE 
SCALE EXPERIMENTAL-CONTROL STD E 
(POSTTEST) (Differences) (Differences) P-Value 
BDI 0.819 0.28 0.785 
HAMD -2.821 -1.08 0.295 
HAS 1. 598 0.62 0.543 
IES-I 1.719 1. 20 0.246 
IES-A 4.853 2.65 0.017 
HLOC-I -0.784 -0.43 0.673 
HLOC-D 0.507 0.29 0.774 










POOLED T-TEST TABLE 
(POST-PRE) 
EXPERIMENTAL 
M STDE p M 
-1.125 2.490 0.643 0.363 
-4.000 1.742 0.165 -0.363 
-0.375 2.329 0.847 -1.000 
1.125 1. 630 0.905 1.363 
2.750 1.810 0.406 0.727 
-2.750 1.485 0.408 -1.181 
-0.125 1.940 0.980 -0.181 
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